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TRPM3 (melastatin-related transient receptor potential 3) is a calcium-permeable
nonselective cation channel that is expressed in various tissues, including insulin-
secreting β-cells and a subset of sensory neurons from trigeminal and dorsal root
ganglia (DRG). TRPM3 can be activated by the neurosteroid pregnenolone sul-
phate (PregS) or heat. TRPM3−/− mice display an impaired sensation of nox-
ious heat and inflammatory thermal hyperalgesia. A calcium-based screening of a
compound library identified four natural compounds as TRPM3 blockers. Three
of the natural compounds belong to the citrus fruit flavanones (hesperetin, erio-
dictyol and naringenin), the forth compound is a deoxybenzoin that can be syn-
thesized from an isoflavone of the root of Ononis spinosa (ononetin). The IC50
for the substances ranged from upper nanomolar to lower micromolar concentra-
tions. Electrophysiological whole-cell measurements as well as calcium measure-
ments confirmed the potency of the compounds to block TRPM3 in DRG neu-
rones. To further improve the potency and the selectivity of TRPM3 block and
to identify the pharmacophore within the flavanone structure, we conducted a hit
optimisation procedure by re-screening a focussed library. The library composed of
several flavanones with different substitutions on relevant chemical positions and of
representatives from different flavonoid subgroups. Within this secondary screen,
we identified isosakuranetin and liquiritigenin as active blockers of PregS-induced
Ca2+ entry through TRPM3. Isosakuranetin, a flavanone that can be found in
blood oranges and grapefruits, displayed an IC50 of 50 nM, and is the most potent
inhibitor of TRPM3 identified so far. The novel compounds exhibited a marked
specificity for TRPM3 compared with other thermosensitive TRP channels, and
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blocked PregS-induced [Ca2+]i signals and ionic currents in freshly isolated DRG
neurones. Furthermore, isosakuranetin and hesperetin reduced the sensitvity of
mice to noxious heat and PregS-induced chemical pain. Since the physiological
functions of TRPM3 channels are still poorly defined, the development and vali-
dation of potent and selective blockers is expected to contribute to clarifying the
role of TRPM3 in vivo. Considering the involvement of TRPM3 in nociception,
TRPM3 blockers may represent a novel concept for analgesic treatment.
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Nomenclature
2-APB . . . . . . . . . 2-aminoethoxydiphenyl borate
aa . . . . . . . . . . . . . . Amino acid
BAA . . . . . . . . . . . Bisandrographolide
CGRP . . . . . . . . . Calcitonin gene related peptide
CNG . . . . . . . . . . . Cyclic nucleotide gated
DRG . . . . . . . . . . . Dorsal root ganglia
nompC . . . . . . . . . No mechanoreceptor potential C
NSAIDs . . . . . . . . Nonsteroidal anti-inflammatory drugs
PPAR-γ . . . . . . . . Peroxisome-proliferator-activated receptor-γ
PregS . . . . . . . . . . Pregnenolone sulphate
THC . . . . . . . . . . . Tetrahydrocannabinol
TM . . . . . . . . . . . . Transmembrane
TRP . . . . . . . . . . . Transient receptor potential
TRPA . . . . . . . . . . Transient receptor potential ankyrin
TRPC . . . . . . . . . . Transient receptor potential canonical
TRPM . . . . . . . . . Transient receptor potential melastatin-related
TRPML . . . . . . . . Transient receptor potential mucolipin
TRPP . . . . . . . . . . Transient receptor potential polycystein
TRPV . . . . . . . . . . Transient receptor potential vanilloid
VR1 . . . . . . . . . . . . Vanilloid receptor 1
1

1 Abstract
Transient receptor potential (TRP) channels are a ubiquitously expressed family
of ion channels that fulfil a plethora of different functions in the organism. They
participate, amongst other functions, in the perception of pain, temperature and
taste, and they are important players in the calcium and magnesium homeosta-
sis. In contrary to other ion channels that have been identified by means of their
ion selectivity or ligands, most TRP channels have been identified on the basis
of sequence homologies. Therefore, specific activators and blockers are lacking
for most TRP channels. In the meantime, functional data obtained from TRP
channel knock-out mouse models helped to identify the physiological function of
some, but not all TRP channels. As a possible drawback of knock-out strate-
gies, proteins with redundant functions might obscure or compensate the missing
protein. Thus, specific modulators are indispensable for the characterisation of
TRP channel functions, especially in in vivo experiments. Genome-wide associa-
tion studies provided evidence that TRP channel mutations are linked to different
diseases. Thus, specific modulators of TRP channels are not only essential for the
characterisation for the TRP channel function but may also bear the potential to
develop novel therapeutic strategies.
TRPM3, the third member of the melastatin-related TRP channel subfamily, is
one of the poorly characterized TRP channels. The TRPM3 gene is transcribed
into different splice variants that differ with respect to their biophysiological prop-
erties. TRPM3α2 is a Ca2+-permeable ion channel that is, together with the closely
related TRPM1, activated by the neurosteroid pregnenolone sulfate (PregS). In
contrast to TRPM3α2, TRPM3α1 is a Ca2+-impermeable, monovalent selective
splice variant, and no activators are known to date. TRPM3α2 is functionally
expressed in the endocrine pancreas, and activation of TRPM3α2 enhances the
insulin secretion. TRPM3α2 is also expressed in neurones of the trigeminal and
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dorsal root ganglia (DRG) and can be activated by temperatures above 37 ◦C.
Data obtained with TRPM3-deficient mice revealed that TRPM3α2 is involved in
the perception of noxious heat and in the development of inflammatory thermal
hyperalgesia. The role of TRPM3α2 in the insulin secretion has yet not been
confirmed in vivo.
The aim of this thesis was to identify modulators of TRPM3α2 that can be
used as pharmacological tools to help to unravel the physiological functions of
TRPM3α2 in vitro and in vivo. Specifically, the function of TRPM3α2 as a puta-
tive heat-sensing nociceptive receptor was investigated in recombinant expression
systems, in primary cells that natively express TRPM3α2 and at the organismic
level in vivo, applying the newly identified blockers. All experiments described in
this thesis have been performed with the Ca2+-permeable TRPM3α2 channel.
A common feature of thermo-sensitive TRP channels is their modulation by nat-
ural compounds. Therefore, we screened a compound library that comprises not
only drugs and drug-like compounds, but also molecularly defined natural com-
pounds and toxins. HEK293 cells stably expressing TRPM3 were loaded with the
calcium indicator dye Fluo-4, dispensed into 384-well plates that were preloaded
with the compounds of the library, and the PregS-induced Ca2+ entry was detected.
As a result of the primary screen, we identified four natural compounds as potent
TRPM3 blockers (Chapter 4). Three of the newly identified inhibitors belong to
the citrus fruit flavanones (hesperetin, eriodictyol and naringenin), the forth com-
pound is a deoxybenzoin that was originally synthesized from an isoflavone of the
root of Ononis spinosa (ononetin). The IC50 for the substances ranged between
0.3 µM for ononetin and 2.0 µM for hesperetin. Citrus fruit flavanones are glycosy-
lated secondary plant metabolites. After consumption of flavanone glycosides, the
sugar moiety is cleaved by intestinal bacteria and the resulting flavanone aglycon
can be resorbed. Naringenin derives from the bitter-tasting naringin that is mainly
found in grapefruits. Hesperetin arose from hesperedin a flavanone that predom-
inantly occurs in oranges. Neither naringin nor hesperedin, the two flavanone
glycosides, had any blocking effect on TRPM3. Whole-cell electrophysiological
measurements were performed to further characterise the potency of naringenin
and ononetin to block TRPM3. This ongoing electrophysiological characterisa-
tion revealed that naringenin and ononetin also block nifedipine- or heat-induced
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TRPM3 currents. Furthermore, the newly identified blockers showed a high speci-
ficity for TRPM3. Neither TRPM1, the most closely related TRP channel, nor
other thermo-sensitive TRP channels (TRPV1, TRPM8, TRPA1) that are ex-
pressed in DRG neurones were blocked by concentrations of the compounds that
are sufficient to completely abrogate TRPM3 activity. Single-cell fluorescence mea-
surements in freshly isolated DRG neurones showed that naringenin and ononetin
also block endogenously expressed TRPM3. Despite low bioavailability and exten-
sive phase 1 and phase 2 metabolism, some studies demonstrated that hesperetin
and naringenin may reach plasma concentrations that would be sufficient to inhibit
TRPM3 in vitro.
The flavonoid substructure comprises two aromatic rings (A and B ring) that
are linked with a heterocycle (C ring). Flavonoids can be divided into different
subgroups, depending on the degree of the oxidation and the substitutions in the
C ring. Based on the compounds identified in the primary screen, we next aimed
at the identification of the pharmacophore within the flavanone structure. To
this end, we constructed a focussed library that contains several flavanones with
different substitutions on relevant chemical positions, and several representative
compounds from other flavonoid subgroups (Chapter 5). At a concentration of
25 µM, flavonoids that do not share the flavanone backbone failed to completely
block the PregS-induced TRPM3 activation. Thus, within the chemical class of
flavonoids, the flavanone substructure represents an optimized substructure. Since
pinocembrin, the unsubstituted flavanone substructure, was only poorly active,
substitutions on the A and B ring are essential to efficiently block TRPM3. In the
secondary screen we identified two novel flavanones that potently blocked TRPM3:
isosakuranetin with an IC50 of 50 nM and liquiritigenin with an IC50 of 500 nM.
Electrophysiological characterisation revealed that isosakuranetin inhibits both,
the PregS- and the heat-induced activation of TRPM3α2. In addition, isosaku-
ranetin can act from either side of the membrane, but the slow onset of block found
upon extracellular application points to an intracellular binding site. Considering
the specificity, liquiritigenin strongly discriminated against other members of the
TRP channel subfamily. High concentrations of isosakuranetin activated recombi-
nantly overexpressed TRPA1, but its impact on endogenously expressed TRPA1
was low. Isosakuranetin blocked TRPM3-induced currents in freshly isolated DRG
5
neurones, but had no inhibitory effect on endogenously expressed TRPA1, TRPM8
and TRPV1. Cytotoxicity tests revealed a marked cytotoxic effect of naringenin,
whereas all other TRPM3-blocking flavanones were well tolerated. For this reason
we chose isosakuranetin and hesperetin to investigate a possible pain-alleviating
effect of the TRPM3 blockers in animal experiments. Mice that were intraperi-
toneally injected with 2 mg/kg or 10 mg/kg of isosakuranetin and placed on a
hot plate (52 ◦C) showed a significantly prolonged latency of nocifensive behaviour
compared to solvent-injected control animals. Intraperitoneal injection of hes-
peretin was also effective at a dose of 10 mg/kg, but not at 2 mg/kg. Intraplantar
injection of PregS elicited a nocifensive behaviour that could be significantly dimin-
ished by previous intraperitoneal injection of 2 mg/kg or 10 mg/kg isosakuranetin.
Plasma concentrations of isosakuranetin after intraperitoneal injection of 2 mg/kg
already reached concentrations that were sufficient to block TRPM3 in vitro.
In the context of this thesis citrus fruit flavanones were identified as potent
and selective TRPM3 blockers. The here identified blockers can be used to in-
vestigate the function of TRPM3 in vitro and in vivo. Furthermore, these novel
pharmacological tools may help to solve the discrepancy between in vitro and in
vivo experiments concerning the role of TRPM3 in insulin secretion. The function
of TRPM3 in DRG neurones is reminiscent of that of the pain-relevant vanil-
loid receptor TRPV1. TRPV1 blockers have been tested in clinical studies as
potentially analgesic drugs. However, inhibition of TRPV1 not only alleviates
heat-induced pain but also increases the body temperature of the subjects. This
body temperature-elevating effect forced the early termination of some clinical tri-
als. Contrary to TRPV1 blockers, isosakuranetin and hesperetin did not elevate
the body temperature of systemically treated mice. Besides its function in the
perception of noxious heat, TRPM3 is involved in the inflammatory thermal hy-
peralgesia. Thus, further experiments are necessary to show whether the novel
TRPM3 blockers are effective in blocking TRPM3-induced thermal hyperalgesia
and may get in focus for the development of novel analgesic therapies.
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2 Zusammenfassung
Transient Receptor Potential (TRP)-Kana¨le sind ubiquita¨r exprimierte Kationen-
kana¨le, die eine Vielzahl unterschiedlicher Funktionen im Organismus erfu¨llen.
Sie sind unter anderem an der Wahrnehmung von Schmerz, Temperatur und Ge-
schmack beteiligt, und spielen eine wichtige Rolle bei der Calcium- und Magnesium-
Homo¨ostase. Viele TRP-Kana¨le sind anders als die meisten anderen Ionenkana¨le
nicht durch ihre Liganden oder ihre Selektivita¨t, sondern u¨ber die Homologie ihrer
Sequenzen identifiziert worden. Dies hat zur Folge, dass nicht fu¨r alle TRP-Kana¨le
spezifische Aktivatoren oder Blocker bekannt sind, und somit die Funktion einzel-
ner TRP-Kana¨le noch weitgehend unbekannt ist. Mit Hilfe transgener knock-out
Mausmodelle konnten zwischenzeitlich einige TRP-Kanalfunktionen gekla¨rt wer-
den.
Ein Nachteil der knock-out-Strategie ist allerdings, dass andere, funktionell red-
undante Proteine teilweise oder vollsta¨ndig den Wegfall des TRP-Kanals kompen-
sieren ko¨nnen und somit mo¨glicherweise der eigentliche Funktionsverlust verschlei-
ert wird. Aus diesem Grund sind spezifische Modulatoren fu¨r die Charakterisierung
der TRP-Kanalfunktion, besonders bei in vivo-Versuchen, unerla¨sslich. Spezifische
Modulatoren sind nicht nur fu¨r die Charakterisierung der TRP-Kanalfunktionen
notwendig, sondern sie ru¨cken auch immer mehr in den Mittelpunkt pharmako-
logischer Forschung, da bei der Kartierung krankheitsrelevanter Loci in genom-
weiten Assoziationsstudien gezeigt wurde, dass Mutationen von TRP-Kana¨len mit
verschiedenen Erkrankungen assoziiert sind. Ein bislang relativ schlecht charakte-
risierter TRP-Kanal ist TRPM3. Das TRPM3-Gen codiert fu¨r eine Vielzahl un-
terschiedlicher Splicevarianten, die sich unter anderem in ihren biophysikalischen
Eigenschaften unterscheiden. Beispielsweise ist die Ca2+-permeable Splicevariante
TRPM3α2, wie ihr engster Verwandter TRPM1, durch das Neurosteroid Pregneno-
lonsulfat (PregS) aktivierbar. Fu¨r die Ca2+-impermeable Splicevariante TRPM3α1
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hingegen sind noch keine Modulatoren bekannt. Entsprechend ist sie daher auch
noch nicht funktionell charakterisiert. Mittels in vitro-Versuchen konnte gezeigt
werden, dass TRPM3α2 funktionell im endokrinen Pankreas exprimiert ist und
es nach Aktivierung des Kanals zu einer versta¨rkten Insulinausschu¨ttung kommt.
TRPM3α2 ist in Neuronen der Trigeminal- und Hinterwurzelganglien exprimiert
und wird durch Temperaturen u¨ber 37 ◦ aktiviert. Experimente mit TRPM3 knock-
out-Ma¨usen zeigten, dass TRPM3 an der Wahrnehmung von schmerzhafter Hitze
sowie inflammatorischer Hyperalgesie beteiligt ist. Eine Relevanz von TRPM3α2
bei der Insulinausschu¨ttung konnte in den knock-out-Tieren in vivo noch nicht
besta¨tigt werden.
Ziel dieser Arbeit war es, mittels eines Screenings Modulatoren fu¨r den Ionenka-
nal TRPM3α2 zu identifizieren um pharmakologische Werkzeuge zu erhalten, die
zur Aufkla¨rung der physiologischen Funktion von TRPM3α2 beitragen ko¨nnen.
Weiterhin sollte mit den identifizierten Blockern die Funktion von TRPM3α2 als
Schmerz- und Hitzerezeptor in vivo untersucht und die Frage gekla¨rt werden, ob
sich TRPM3α2 als potenzielle Zielstruktur fu¨r die pharmakologische Forschung
zur Entwicklung von Analgetika eignet. Alle Experimente mit rekombinantem
TRPM3, die im Rahmen dieser Arbeit dargestellt sind, wurden mit der Ca2+-
permeablen TRPM3α2-Variante durchgefu¨hrt.
Eine Gemeinsamkeit der thermo-aktivierbaren TRP-Kana¨le ist ihre Modulier-
barkeit durch Naturstoffe. Daher wurde eine Substanzbibliothek zum Screening
ausgewa¨hlt, die neben zahlreichen zugelassenen Medikamenten auch Naturstof-
fe und Toxine entha¨lt. In Chapter 4 sind die Ergebnisse des prima¨ren Screens
dargestellt. Eine HEK293-Zelllinie, die stabil TRPM3 exprimiert, wurde mit den
verschiedenen Substanzen der Bibliothek inkubiert und der Ca2+-Einstrom, aus-
gelo¨st durch den TRPM3-Aktivator PregS, fluorometrisch gemessen. Durch weite-
re Optimierungsschritte wurden vier verschiedene Naturstoffe als TRPM3-Blocker
identifiziert. Darunter befanden sich drei Flavanone aus Zitrusfru¨chten (Hespe-
retin, Eriodictyol und Naringenin) und ein Deoxybenzoin, welches urspru¨nglich
aus einem Isoflavon der Wurzel von Ononis spinosa gewonnen wurde (Ononetin).
Die IC50-Werte der Substanzen lagen zwischen 0,3 µM fu¨r Ononetin und 2,0 µM
fu¨r Hesperetin. Flavanone kommen in der Natur nur als Glykosid vor. Erst im
Darm wird der Zucker durch Bakterien abgespalten, so dass das entsprechende
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Flavanon-Aglykon entsteht und resorbiert werden kann. Naringenin entsteht so
aus dem in Grapefruit vorkommenden, bitter schmeckenden Naringin. Hesperetin
entsteht aus Hesperedin, einem vor allem in Orangen vorkommenden Flavanon-
Glycosid. Die Flavanon-Glykoside selbst (Naringin und Hesperedin) zeigten kei-
nerlei hemmende Wirkung auf TRPM3. Eine weiterfu¨hrende elektrophysiologische
Charakterisierung zeigte, dass auch die durch Nifedipin oder Hitze ausgelo¨sten
TRPM3-Stro¨me durch Naringenin und Ononetin blockierbar sind. Weiterhin zeig-
ten die neu entdeckten TRPM3-Blocker eine hohe Spezifita¨t. Weder TRPM1, der
engste Verwandte von TRPM3, noch andere, in Neuronen der Hinterwurzelgangli-
en exprimierte, thermo-sensitive TRP-Kana¨le (TRPV1, TRPM8, TRPA1) wurden
durch die Modulatoren in den fu¨r die TRPM3-Blockade notwendigen Konzentra-
tionen blockiert. Einzelzell-Fluoreszenzmessungen zeigten, dass Naringenin und
Ononetin auch den in sensorischen Neuronen des Hinterwurzelganglions endogen
exprimierten TRPM3 blockieren. Trotz geringer Bioverfu¨gbarkeit von Naringenin
und Hesperetin gelang es bei einigen Studien im Plasma einzelner Individuen,
nach deren Konsum von sehr großen Mengen an Orangensaft oder Grapefruit-
saft, bereits Konzentrationen von Naringenin und Hesperetin nachzuweisen, die
ausreichend wa¨ren um TRPM3 in vitro zu blockieren.
Die Flavonoid-Grundstruktur besteht aus zwei aromatischen Ringen (A und
B), die u¨ber eine heterozyklische Bru¨cke (C-Ring) miteinander verbunden sind.
Es existieren verschiedene Flavonoid-Untergruppen, die sich in ihrem Oxidations-
grad, sowie den Substituenten am C-Ring unterscheiden. Ausgehend von den im
Prima¨rscreen identifizierten Substanzen wurden zur Identifizierung des Phama-
kophors verschiedene Flavanone ausgesucht, welche sich durch unterschiedliche
Substituenten an relevanten Stellen der Flavanon-Grundstruktur unterscheiden.
Zusa¨tzlich wurden einzelne Vertreter unterschiedlicher Flavonoid-Untergruppen
ausgewa¨hlt, und die Potenz TRPM3 zu blockieren, wurde fu¨r diese chemisch unter-
schiedlichen Entita¨ten fluorometrisch bestimmt (Chapter 5). Keine der zusa¨tzlich
untersuchten Flavonoid-Untergruppen zeigte bei einer Konzentration von 25 µM
einen vollsta¨ndigen Block der PregS-induzierten TRPM3-Aktivita¨t, sodass die
Flavanon-Grundstruktur innerhalb dieser chemischen Klasse bereits das Optimum
darstellt. Weiterhin zeigte sich, dass die Flavanone Grundstruktur allein noch nicht
ausreicht, um TRPM3 vollsta¨ndig zu blockieren. Sowohl Substituenten am A-
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Ring, als auch am B-Ring sind fu¨r eine effektive Inhibition no¨tig. Es konnten zwei
weitere Flavanone identifiziert werden, die TRPM3 mit hoher Potenz blockieren:
Isosakuranetin mit einer IC50 von 50 nM und Liquiritigenin mit einer IC50 von
500 nM. Isosakuranetin wurde elektrophysiologisch charakterisiert, und es konn-
te gezeigt werden, dass neben PregS-induzierten TRPM3-Stro¨men auch Hitze-
induzierte TRPM3-Stro¨me blockierbar sind. Die Bindestelle fu¨r Isosakuranetin ist
von beiden Seiten der Membran zuga¨nglich, wobei die langsame Anfangskinetik des
Blocks auf eine intrazellula¨re Bindestelle hinweist. Hinsichtlich der Spezifita¨t zeigte
sich, dass Liquiritigenin am sta¨rksten zwischen den einzelnen TRP-Kana¨len diskri-
miniert. Hohe Konzentrationen von Isosakuranetin aktivieren hingegen TRPA1 in
u¨berexprimierenden Zellen. Dennoch war auf endogen exprimierten TRPA1 nur ein
sehr geringer Einfluss nachweisbar. Isosakuranetin blockiert endogen exprimierten
TRPM3 in sensorischen Neuronen, zeigte jedoch keinen blockierenden Einfluss auf
endogen exprimierten TRPV1, TRPA1 und TRPM8. In Zelltoxizita¨ts-Tests zeigte
sich, dass unter den untersuchten TRPM3-blockierenden Substanzen nur Narin-
genin gravierende zellscha¨digende Eigenschaften aufweist. Daher wurden Isosaku-
ranetin und das bereits im Prima¨rscreen identifizierte Hesperetin verwendet um
die Substanzen im Tierversuch auf ihre schmerzhemmende Wirkung hin zu unter-
suchen. Etwa 30 Minuten nach intraperitonealer Injektion von 2 mg/kg oder 10
mg/kg Isosakuranetin zeigte sich, dass die Ma¨use auf einer heißen Platte (52 ◦C;
hot-plate-Assay) eine verla¨ngerte Latenzzeit hatten, bevor sie ein nozifensives Ver-
halten zeigten. Die Tiere, die den schwa¨cher potenten TRPM3-Blocker Hesperetin
gespritzt bekamen, zeigten nur nach der Injektion der ho¨heren Dosierung von 10
mg/kg eine statistisch signifikant verla¨ngerte Verweildauer auf der heißen Plat-
te. Des weiteren konnten wir zeigen, dass die durch PregS-Injektion ausgelo¨ste
nozifensive Reaktion der Ma¨use durch vorherige Injektion von Isosakuranetin (2
und 10 mg/kg) signifikant geringer ausfiel. Bereits nach intraperitonealer Injekti-
on von 2 mg/kg erreichte die Plasmakonzentration von Isosakuranetin Werte, die
ausreichend sind, um TRPM3 in vitro zu blockieren.
Im Rahmen dieser Arbeit konnte gezeigt werden, dass TRPM3 durch Flavano-
ne aus Zitrusfru¨chten selektiv und potent blockiert wird. Die neu identifizierten
Blocker sind sowohl fu¨r in vitro- als auch fu¨r in vivo-Versuche anwendbar. Die
neuen pharmakologischen Werkzeuge ko¨nnen nun dazu genutzt werden, die Dis-
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krepanz der Ergebnisse zwischen den in vitro-Versuchen und den Befunden in der
knock-out-Maus bezu¨glich der Bedeutung von TRPM3 bei der Insulin-Sekretion
zu kla¨ren. TRPM3 zeigt in nozizeptiven Neuronen a¨hnliche Funktionen, wie der
Schmerz-relevante TRPV1. TRPV1-Blocker wurden bereits in klinischen Studi-
en gepru¨ft. Allerdings bewirkte eine Blockade von TRPV1 nicht nur analgetische
Effekte, sondern auch die Ko¨rpertemperatur wurde erho¨ht. Dies fu¨hrte zum vor-
zeitigen Abbruch einiger klinischer Studien. Im Gegensatz zu TRPV1-Blockern
zeigten Isosakuranetin und Hesperetin keinen Einfluss auf die Ko¨rpertemperatur
systemisch behandelter Ma¨use. TRPM3 ist nicht nur an der Wahrnehmung von
schmerzhafter Hitze, sondern auch an der inflammatorischen Hyperalgesie betei-
ligt. Daher sind weitere Versuche no¨tig um zu pru¨fen, ob die neu identifizierten
Blocker auch die u¨ber TRPM3 ausgelo¨ste inflammatorische Hyperalgesie blockie-
ren ko¨nnen. Sollten weiterfu¨hrende Experimente mit TRPM3 dessen Funktion als
Schmerzrezeptor auch bei Entzu¨ndungsreaktionen besta¨tigen, ko¨nnte diese Ziel-
struktur zur Entwicklung neuer analgetischer Therapieansa¨tze an Bedeutung ge-
winnen.
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3 Introduction
Ion channels are integral membrane proteins that form water-filled pores through
cell membranes (plasma membranes or intracellular organelle membranes) that
allow the movement of ions across the membrane along their electrochemical gra-
dients. Typically, ion channels are oligomeric complexes of several subunits, ar-
ranged in circular symmetry to form a central pore. They allow millions of ions
per second to permeate the membrane to change the membrane potential or intra-
cellular ion concentrations. Various mechanisms may lead to channel activation.
They include changes in membrane potential, increases in intracellular Ca2+, bind-
ing of neurotransmitters or other ligands, changes in intracellular levels of second
messengers, or pH1.
3.1 Helix-loop-helix superfamily of cation channels
Cation channels can be divided into several superfamilies with strongly divergent
structures and functional features: voltage-gated channels, ligand-gated channels,
second messenger-operated channels and store-operated channels. In the human
genome, helix-loop-helix-type ion channels form the largest superfamily, including
the voltage-gated Ca2+, Na+ and K+ channels. A common feature of the voltage-
gated ion channels is their four-fold symmetry, with a central pore domain that is
surrounded by the voltage-sensor regions2. Each of the channel domains contains
six transmembrane (TM) segments. The pore of the voltage-gated ion channels
is formed by transmembrane-spanning α-helices S5 and S6, flanking a membrane-
reentrant loop that forms the selectivity filter1. The transmembrane segment
S4 contains several positively charged amino acids, providing the voltage-sensor
domain.
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Fig 3.1: A phylogenetic tree of the TRP family. Mammalian TRP channels are grouped
into six subfamilies that comprise distinct channel properties. TRPC2 is a pseudogene in humans
and the TRPN family is absent in mammals. Figure is taken from Nilius et al. 20114.
Apart from the voltage-gated ion channels the superfamily also comprises hyper-
polarisation-activated (HCN) and weakly voltage-dependent ion channels, includ-
ing cyclic nucleotide-gated (CNG) and transient receptor potential (TRP) chan-
nels2,3.
3.2 Transient receptor potential channels
Most TRP channels are non-selective cation channels that can lead to cell de-
polarisation or transmit a Ca2+ entry. They were first described in Drosophila
melanogaster, where a mutation showed a transient rather than a sustained re-
sponse, when exposed to continuous light5. This mutant was called transient
receptor potential, and it took 20 years to finally identify the trp gene6. Based on
their amino acid sequence similarity about 30 different mammalian TRP channels
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have been identified so far (Fig. 3.1). The mamailian TRP channels are grouped
into six subfamilies7:
1. TRPC (canonical or classical): The TRPC group contains the proteins with
the highest similarity to the Drosophila TRP channels.
2. TRPM (melastatin-related): The name was given to the group because of
the tumour suppressor melastatin (TRPM1), the founding member of the
TRPM family.
3. TRPV (vanilloid): The group was named vanilloid because of the vanilloid
compound capsaicin, the ligand of the first member, vanilloid receptor 1
(VR1, now TRPV1).
4. TRPA (ankyrin): The name of the group derived from the protein ankyrin-
like with transmembrane domains 1 (ANKTM1, now TRPA1). TRPA1 is
the only member of this subfamily in mammals.
5. TRPML (mucolipin): This group was named after mucolipin 1 (TRPML1),
the founding member of the mucolipin subfamily.
6. TRPP (polycystin): Named after the polycystic kidney disease-related pro-
tein 2 (PKD2, now TRPP2).
In invertebrates and fishes an additional TRP subfamily has appeared: the so-
called TRPN (NOMPC-like) family. The name derived from the no mechanore-
ceptor potential C (nompC) gene from Drosophila. For more information about
the TRP channel subfamilies see Clapham 20038.
Like voltage-gated K+ channels, TRP channels feature six transmembrane-
spanning segments (S1-S6) and both termini are located intracellularly (Fig. 3.2A).
To form a functional ion channel, four TRP subunits assemble, and S5 and S6,
together with the connecting loop, form the predicted cation-conducting pore9,10.
The tetrameric stoichiometry allows homomeric or heteromeric arrangements of
subunits from the same subfamily (for review see Schaefer 200511). First struc-
tural insight into the architecture of the TRP ion channels came from the crystal
structure of the bacterial cation channel KcsA from the bacterium Streptomyces
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lividans 12 (Fig. 3.2B). KcsA is a two TM channel with an amino acid sequence of
the pore region that closely resembles that of vertebrate voltage-gated K+ chan-
nels12, and bears sequence homology to the TRP channel pore region13. Point
mutations in the connecting loop of TRPV channels affect the ion permeability
of the respective TRP channel and foster the function of the linker as the core
selectivity filter of TRP channels9,14.
Fig 3.2: Topology of TRP channels and architecture of the pore region. (A) TRP
channels comprise six transmembrane-spanning segments with intracellularly located N- and C-
terminal tails. The putative pore is located between S5 and S6 and the selectivity filter is formed
by the connecting loop that dips into the membrane. (B) Schematic ribbon model of the typical
helix-loop-helix pore structure of cation channels. Shown is the pore region of the bacterial 2 TM
channel KcsA (only two subunits are shown). The connecting loop that forms the selectivity filter
is shown as ball-and-stick model with K+ ions (blue balls) bound in the permeation pathway.
(A) is modified from Clampham 200115; (B) is obtained from Owsianik 200613.
Carboxyl and amino termini contain structural and functional motifs or domains
that differ between different TRP channel subfamilies. These cytosolic domains
may be important for the assembly and regulation of the channel by intracellu-
lar signalling cascades. An example for such domains are the ankyrin repeats
located at the N-terminus in TRPC, TRPN, TRPV and TRPA channels and are
expected to provide binding sites for interaction partners16. Further regulatory
motifs include the TRP domain, coiled-coil motifs, calmodulin binding sites, lipid
interaction domains, EF hands and phosphorylation sites (for more information
see Owsianik 200617). Some members of the TRPM subfamily have, besides their
function as an ion channel, an enzyme domain on their carboxy terminus: TRPM2
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contains a Nudix hydroxylase domain that functions as an ADP ribose pyrophos-
phatase18, TRPM6 and TRPM7 contain an atypical α-kinase domain19,20. Their
naming as ”chanzymes” refers to a possible bimodal function of these large pro-
teins.
3.3 TRP channels as temperature sensors
In complex organisms, thermosensation is essential to avoid noxious temperatures
that may result in tissue damage. Thermosensory afferent neurones project into
the dorsal horn of the spinal cord, where glutamatergic synapses contact and
activate the second neuron of the pain pathway. Different TRP channels that are
expressed in sensory nerve endings or in keratinocytes are involved in the detection
of innocuous and noxious temperatures21.
TRPV1 was the first cloned thermosensitive TRP channel. In resting cells, it
features a thermal activation threshold of about 43 ◦C. TRPV1 has been iden-
tified in an expression cloning approach with capsaicin, the active component of
chili peppers, and resiniferatoxin, an extremely potent capsaicin analogue from
Euphorbia plants22. The vanilloid moiety of these compounds was name-giving
for the newly identified cDNA as VR1, for vanilloid receptor subtype 122. In
the meantime, a plethora of different compounds that modulate TRPV1 has been
identified, for review see Vriens 200823. TRPV1 is predominantly expressed in
small and medium diameter primary sensory neurones Aδ and C fibers24. Besides
TRPV1, nine other mammalian TRP ion channels are also activated by changes
in temperature22,25–33. Six of them are currently classified as thermo-TRPs be-
cause of their expression in primary somatosensory neurones and their ability to
be activated by cold (TRPM8, TRPA1)34, warm (TRPV3, TRPV4), or hot tem-
peratures (TRPV1, TRPV2) (Fig.3.3). TRPV2 has been identified by homology
cloning25. In contrast to TRPV1, TRPV2 is insensitive to capsaicin, and its acti-
vation threshold is 52 ◦C25. TRPV2 is expressed in a subpopulation of medium-
diameter Aδ sensory neurones that respond to high-threshold noxious heat, but its
contribution to the thermosensation still remains elusive: TRPV2 knock-out mice
display normal thermal and mechanical nociception35. The temperature threshold
for TRPV3 and TRPV4 activation is within the physiological temperature range
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of skin temperatures 25-34 ◦C. TRPV3 is mainly expressed in keratinocytes of
the skin, but not in sensory neurones of mice26. However, in studies with human
and monkey tissues TRPV3 expression has been found in sensory neurones36,37.
Mice lacking TRPV3 expression have an impaired thermosensation, indicating its
involvement in innocuous warm sensation38. Besides warm temperatures, TRPV3
is activated by natural compounds that, in humans, exert a pleasantly warm sen-
sation. Similar to TRPV3, TRPV4 expression in thermosensory neurones is still
Fig 3.3: Schematic representation of the classical thermo-TRP channel that sense
temperatures from noxious cold to noxious heat. The temperature range for the activation
of the respective TRP channel is indicated on the thermometer. Various natural compounds
modulate the thermo-TRPs, prominent modulators are indicated in the figure. The figure is
modified from Vay 201234.BAA = bisandrographolide A; THC = tetrahydrocannabinol
controversially discussed27,39,40. Studies with TRPV4−/− mice have shown that
TRPV4 participates in the detection of warmth in the sensory system41. TRPV4
is also activated by nonthermal activators, such as the endocannabinoid anan-
damide, its metabolites42 and synthetic phorbol esters. The perception of cold
can, similar to heat, range from mild to painful cold. TRPM8 has been identi-
fied as a receptor for the cooling compound menthol and temperatures below 20
◦C28,29. TRPM8 is expressed in non-peptidergic small-diameter sensory neurones
that do not express substance P, calcitonin gene related peptide (CGRP)29, and
18
TRPV130. This, together with the fact that TRPM8−/− mice show deficits to
sense moderately cold temperatures43–45, indicates an important role of TRPM8
in the detection of innocuous cold. TRPA1 is highly expressed in a subset of small
to medium diameter peripheral sensory neurones that also express TRPV1 but
not TRPM830. The threshold to activate TRPA1 in a heterologous expression
system is in the noxious cold range (below 17 ◦C)30. However, the activation of
TRPA1 by noxious cold is still under debate: a study with TRPA1−/− mice has
shown that TRPA1 is not required for noxious cold sensation46,47, whereas in an-
other study TRPA1−/− mice had displayed an impaired sensation of intense cold
temperature48. One should note that TRPA1 is activated by a rise in intracellular
Ca2+ concentrations. Thus, cooling cells down may indirectly activate TRPA1
through an increase in [Ca2+]i
49,50. Further activators for TRPA1 are different
plant-derived compounds and irritants that elicit pain and inflammation in hu-
mans such as allyl isothiocyanate the major active ingredient of mustard oil51,
cinnamaldehyde from cinnamon, eugenol and gingerol52.
In 2011, TRPM3 has been identified as an ion channel that is expressed in
sensory neurones and activated by temperatures above 37 ◦C31. Within the fam-
ily of TRPM channels, three other members (TRPM2, TRPM4 and TRPM5)
are modulated by temperature, but their relevance in thermosensation has not
been firmly established so far32,33. Recently, mRNA of the newly identified ther-
mosensitive TRPM (TRPM2-TRPM5) channels has been detected in dorsal root
ganglia (DRG) of mice53,54, but only TRPM331 and TRPM2 currents55 have been
measured. Interestingly, thermosensitive TRPM4 and TRPM5 channels are also
co-expressed in pancreatic β-cells and contribute to insulin secretion (for review
see Uchida 201156).
3.4 TRPM3
TRPM3 is a member of the subfamily of melastatin-related TRP channels. The
TRPM3 gene encodes a plethora of different splice variants. Lee et al. have identi-
fied six TRPM3 splice variants in humans (TRPM3a-f), ranging from 1544 to 1579
amino acids (aa) in length57. An additional human TRPM31325 variant has been
identified, which in contrary to the TRPM3a-f variants, consists only of 1325 aa
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and exhibits a shorter C-terminus and 153 additional aa on its N-terminus58. The
TRPM31325 and TRPM3a variants form both Ca
2+-permeable and constitutively
active channels when heterologously expressed in HEK293 cells57,58. In mice, five
TRPM3 splice variants have been described by Oberwinkler et al. in 2005. These
splice variants contain a previously not known sequence of 61 aa on their amino
terminus59. Alternative splicing in a region that encodes the putative pore region
results in TRPM3 proteins with different biophysiological properties. TRPM3α1 is
permeable for monovalent cations but not for divalent cations, whereas TRPM3α2
is poorly selective and Ca2+-permeable59. Within the pore loop, TRPM3α2 re-
sembles the human TRPM3 splice variants.
Fig 3.4: Schematic representation of different TRPM3 variants. The complete TRPM3
protein is shown as yellow bar, with the different spliced exons (orange), the alternative N-termini
(blue), and the TM segments (grey). Different splice variants are indicated as black bars with
the total size of the protein indicated in brackets. TRPM3α1 is a 12 aa longer splice variant
compared to TRPM3α2, this difference results in TRPM3 channels with different ion selectivity.
The aa differences are indicated as insertion. The figure is modified from Oberwinkler 2005,
Fruehwald 201260,61.
TRPM3 is expressed in various neuronal and nonneuronal tissues including kid-
ney, eye, pancreas, brain, DRG and trigeminal neurones57–59,62,63. TRPM3α2 can
be activated by the neurosteroid pregnenolone sulphate (PregS), high concentra-
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tions of nifedipine64, D-erythro-sphingosine65 or noxious heat31. The physiological
role of TRPM3 is still not firmly established. TRPM3 is expressed in insulin-
secreting β-cells and has been linked to insulin secretion64, and Zn2+ uptake in
β-cells66. However, the importance of TRPM3 to regulate insulin secretion is still
under debate, since TRPM3−/− mice were not different from wildtype mice con-
cerning resting blood glucose level and body weight31. TRPM3 is expressed in
different cell types in the eye, including the retinal pigment epithelium, ciliary
body and Mu¨ller cells67. Notably, TRPM3−/− mice show a diminished pupillary
response to bright light63. Besides the attenuated pupil constriction of TRPM3−/−
mice, no functional data of the channel is available for TRPM3-expressing cells of
the eye. Other data concerning TRPM3 reveals its involvement in the glutamater-
gic transmission at cerebellar Purkinje neurones, but no functional activation of
TRPM3 with PregS or other activators has been shown68. TRPM3 has been found
in oligodendrocytes, and during the oligodendrocyte differentiation different splice
variants of TRPM3 are expressed69. Furthermore, TRPM3 is expressed in synovial
fibroblasts and activation of TRPM3 by PregS or sphingosine causes a decrease in
the hyaluronan secretion70. In vascular smooth muscle cells, activation of TRPM3
has been shown to suppress cytokine secretion71. TRPM3 is expressed in DRG and
trigeminal neurones and is involved in the detection of noxious heat31. Elevating
the temperature above 37 ◦C strongly activates TRPM3, and TRPM3−/− mice
showed impaired behavioural responses to noxious heat and in the development of
inflammatory thermal hyperalgesia31.
3.5 Pharmacological modulation of TRPM3
Since the physiological significance of TRPM3-mediated effects is still not unam-
biguously established, substances that potently and selectively inhibit TRPM3
in vitro and in vivo may help to clarify the physiological function of TRPM3.
The advantage of pharmacological inhibition of an ion channel is, in contrary to
knock-out animals, that compensatory effects of redundant proteins could not be
accomplished so fast. Previously published inhibitors of TRPM3 include unspe-
cific TRP blockers like 2-aminoethoxydiphenyl borate (2-APB)72 and gadolinium
ions57. Other modulators of TRPM3 are the peroxisome-proliferator-activated
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receptor-γ-agonists (PPAR-γ) rosiglitazone and troglitazone that are used for
the treatment of type-2 diabetes73, and the nonsteroidal anti-inflammatory drugs
(NSAIDs) mefenamic acid and tolfenamic acid74. All recently published blockers
may be helpful tools to investigate the function of TRPM3 in vitro, but are not
applicable for in vivo experiments because of significant off-target effects of the
required modulator concentrations.
3.6 Aim of the thesis and systematic approach
Specific modulators for TRP channels help to identify activation mechanisms for
the respective channels and lead to an improved understanding of the physiological
and pathophysiological roles of these channels. TRPM3 is still poorly characterized
and the aim of this thesis was to identify modulators of the Ca2+-permeable ion
channel TRPM3α2 that can be used as pharmacological tool to help to identify the
function of TRPM3 in vivo. Since TRPM3 is involved in the detection of noxious
heat and inflammatory-induced hyperalgesia, the newly identified TRPM3 blockers
were used to investigate the function of TRPM3 as pain and heat receptor in vivo.
To identify modulators of TRPM3, we performed a medium throughput screen-
ing with a compound library containing 2000 drugs, drug-like molecules, toxins
and natural compounds (Chapter 4). In this primary screen four compounds
were identified that completely block TRPM3 at a concentration of 20 µM. The
newly identified TRPM3 blockers are plant-derived flavonoids, and three of them
belong to the group of citrus fruit flavanones.
Flavanoids are plant secondary metabolites that contribute to the flower coloura-
tion and are, in higher plants, involved in the defence against ultraviolet radia-
tion75. They chemically derive from the flavan substructure and are composed
of two aromatic cycles (A ring and B ring), that are linked with a heterocycle
(C ring) (Fig 3.5). Flavonoids can be divided into different subgroups depending
on the oxidation state in the C ring, the hydroxylation patterns of the A and B
rings and the substitution on the C3 position76. They naturally occur in fruit and
vegetables and are, thus, an important part of the human diet. The daily intake
of flavonoids of adults has been estimated to amount around 200 mg/d77. Major
dietary sources of flavonoids are tea, citrus fruits and citrus fruit juices as well as
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wine. Because of the large quantity of citrus fruit juice intake, approximately 7.6 %
of the total amount of alimentary flavonoids are citrus fruit flavanones77. Different
clinical and preclinical studies have shown that citrus fruit flavanone consumption
contributes to cardiovascular protection (for review see Chanet 201278). In most
of these clinical and preclinical studies, the effect of the flavonoids was elvaluated
with a focus on cancer and coronary heart disease. The results of these studies
have been inconclusive, since some studies report beneficial effects whereas others
did find no or even potentially harmful effects79. However, the bioavailability of
most flavonoids is limited and concentrations used for in vitro experiments are
often very high78.
Fig 3.5: Molecular structure of the flavan backbone. The flavan backbone consists of two
aromatic rings (A ring and B ring) that are linked together with a heterocycle (C ring).
Since the bioavailability of citrus fruits flavanones is relatively small and the
ingested flavanones were intensively metabolised80, we searched for chemically re-
lated flavanones that display favourable properties with respect to their bioavail-
ability and their inhibitory potency. For this reason, flavonoids from different
subgroups and flavanones that bear different substitutions on relevant chemical
positions were tested for their ability to block TRPM3. Since the novel TRPM3
blockers should be used for in vivo studies, the cytotoxicity of each compound
was determined. Two non-toxic TRPM3 blockers were chosen to be applied in
in vivo experiments. The ability of the TRPM3 blockers to diminish PregS- and
heat-induced nocifensive behaviour in vivo was investigated.
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3.7 Relationship of the publications
The first publication summarizes the results from the primary screen (Chapter 4).
Three of the four idendified TRPM3 blockers belong to the citrus fruit flavanones
(naringenin, hesperetin and eriodictyol) and the fourth compound is a fabacea sec-
ondary metabolite (ononetin). The IC50 for the compounds ranged from 0.3 and
0.5 µM for ononetin and naringenin to 1.0 µM and 2.2 µM for eriodictyol and
hesperetin, respectively. Besides the potency of the compounds to block TRPM3,
we investigated the selectivity of the TRPM3 blockers to discriminate between
other TRP channels. Furthermore, the ability of naringenin and ononetin to
block endogenously expressed TRPM3 was tested in DRG neurones. Based on
the TRPM3-blocking compounds identified in the first screen, we tried to narrow
down and optimise the phamacophore within the flavanone and flavonoid structure
in a second screen (Chapter 5). Except for flavanones, no other tested flavonoid
blocked TRPM3 in concentrations up to 25 µM, indicating that the flavanone
substructure already represents an optimized backbone structure. Within the sec-
ondary screen, we identified isosakuranetin and liquiritigenin as novel TRPM3
blockers that were, compared to the previously identified TRPM3 blockers, either
more potent (isosakuranetin IC50 = 50 nM) or more selective (liquiritigenin) . Fur-
thermore, two TRPM3 blockers (isosakurantin and hesperetin) diminished PregS-
and noxious heat-induced nocifensive behaviour of mice. To obtain information
about the bioavailability of isosakuranetin, the plasma concentrations of intrape-
riotenally injected isosakuranetin was measured at different time points after the
injection.
The function of TRPM3 in DRG neurones is similar to the pain-relevant TRPV1,
and TRPV1 blockers have been investigated as potential analgesic drugs in clinical
studies. However, besides their analgesic effect, TRPV1 blockers elevate the body
temperature of the subjects in clinical studies, and thus, some clinical trials were
stopped81. In contrary to TRPV1 blockers, neither isosakuranetin nor hesperetin
elevated the body temperature of systemically treated mice. In conclusion, our in
vivo experiments confirmed TRPM3 as a receptor for noxious heat. Furthermore,
we showed that TRPM3 can be blocked by citrus fruit flavanones in vitro and in
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vivo, and thus, flavanones can be used as a starting point for the development of
novel analgesic therapies by targeting TRPM3.
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BACKGROUND AND PURPOSE
The melastatin-related transient receptor potential TRPM3 is a calcium-permeable nonselective cation channel that can be
activated by the neurosteroid pregnenolone sulphate (PregS) and heat. TRPM3-deficient mice show an impaired perception of
noxious heat. Hence, drugs inhibiting TRPM3 possibly get in focus of analgesic therapy.
EXPERIMENTAL APPROACH
Fluorometric methods were used to identify novel TRPM3-blocking compounds and to characterize their potency and
selectivity to block TRPM3 but not other sensory TRP channels. Biophysical properties of the block were assessed using
electrophysiological methods. Single cell calcium measurements confirmed the block of endogenously expressed TRPM3
channels in rat and mouse dorsal root ganglion (DRG) neurones.
KEY RESULTS
By screening a compound library, we identified three natural compounds as potent blockers of TRPM3. Naringenin and
hesperetin belong to the citrus fruit flavanones, and ononetin is a deoxybenzoin. Eriodictyol, a metabolite of naringenin and
hesperetin, was still biologically active as a TRPM3 blocker. The compounds exhibited a marked specificity for recombinant
TRPM3 and blocked PregS-induced [Ca2+]i signals in freshly isolated DRG neurones.
CONCLUSION AND IMPLICATIONS
The data indicate that citrus fruit flavonoids are potent and selective blockers of TRPM3. Their potencies ranged from upper
nanomolar to lower micromolar concentrations. Since physiological functions of TRPM3 channels are still poorly defined, the
development and validation of potent and selective blockers is expected to contribute to clarifying the role of TRPM3 in vivo.
Considering the involvement of TRPM3 in nociception, TRPM3 blockers may represent a novel concept for analgesic
treatment.
Abbreviations
[Ca2+]i, intracellular free Ca2+ concentration; DRG, dorsal root ganglion; HBS, HEPES-buffered solution; NSAIDs,
non-steroidal anti-inflammatory drug; PregS, pregnenolone sulphate; TRPA, transient receptor potential ankyrin-like;
TRPM, transient receptor potential melastatin-related; TRPV, transient receptor potential vanilloid-related
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Introduction
TRPM3, the third member of the melastatin-related TRPM
channel subfamily, is still poorly characterized. The TRPM3
gene is transcribed into different alternative splice variants.
Alternative splicing in a region that encodes the putative pore
region of TRPM3 changes the selectivity of ion permeation.
Whereas the TRPM3a2 variant is a calcium-permeable, poorly
selective cation channel, TRPM3a1 features 12 additional
amino acids within the pore domain and is selective for
monovalent cations (Oberwinkler et al., 2005). In this manu-
script, we focus on the TRPM3a2 variant, which is expressed
in various neuronal and non-neuronal tissues and can be
activated by the neurosteroid pregnenolone sulphate (PregS)
or high concentrations of nifedipine (Wagner et al., 2008),
by noxious heat (Vriens et al., 2011), and by D-erythro-
sphingosine (Grimm et al., 2005).
The physiological role of TRPM3 is still not firmly estab-
lished. PregS-induced activation of TRPM3 has been linked to
insulin secretion in pancreatic beta-cells (Wagner et al.,
2008), to vascular smooth muscle cell contraction (Naylor
et al., 2010), and to potentiation of glutamatergic transmis-
sion in cerbellar Purkinje neurons from developing rats
(Zamudio-Bulcock et al., 2011). Recently, Vriens et al.
observed that TRPM3-deficient mice show an impaired per-
ception of noxious heat. Hence, drugs inhibiting TRPM3 may
provide novel instruments for analgesic therapy. In addition,
TRPM3 blockers may help to unravel biological functions of
TRPM3 that might be obscured by compensatory effects in
gene targeting or knock-down approaches.
TRPM3 channel blockers described so far include the
antidiabetic PPARg-agonists rosiglitazone and troglitazone
(Majeed et al., 2011) and nonsteroidal anti-inflammatory
drugs (NSAIDs) of the fenamate group (Klose et al., 2011).
Furthermore, TRPM3 is blocked by 2-APB (Xu et al., 2005) or
by lanthanum and gadolinium ions (Harteneck and Schultz,
2007) that block a plethora of different TRP channels.
By screening a compound library, we identified three
natural compounds as potent TRPM3 blockers. Two of them,
naringenin and hesperetin, belong to the citrus fruit fla-
vanones and ononetin is a deoxybenzoin. Based on its struc-
tural similarity to naringenin and hesperetin, we also
identified eriodictyol as a potent TRPM3 blocker. Further-
more, we confirm the biological activity of naringenin, onon-
etin and eriodictyol in natively TRPM3-expressing dorsal root
ganglia (DRG) neurones.
Methods
Cell culture
HEK293 cells used for transient transfection with TRPM1
were cultured in MEM medium (Invitrogen, Darmstadt,
Germany) containing 10% FCS at 37°C and 5% CO2. Cells
were passaged one to three times a week. HEK293 cells were
cultured in Earle’s Minimum Essential Medium supple-
mented with 10% fetal calf serum, 2 mM L-glutamine, 100
units·mL-1 penicillin, 0.1 mg·mL-1 streptomycin. For genera-
tion of a HEK293 cell line stably expressing myc-tagged
mouse TRPM3a2 (HEKmTRPM3), the cDNA of the myc epitope
was introduced in frame after the start codon of the TRPM3a2
cDNA (GenBank accession AJ544535), ligated into pcDNA3
and transfected into HEK293 cells. Transfected cells were
selected in a medium containing 500 mg·mL-1 G418 for 4
weeks. Single cells were separated by FACS on a MoFlo cell
sorter (Beckmann Coulter, Krefeld, Germany) and expanded.
Clones were tested in Western blots using monoclonal anti-
TRPM3 and anti-myc antibodies, and analysed for PregS-
induced Ca2+ signals in single cell calcium measurement
experiments. HEK293 cells stably expressing other sensory
TRP channels (HEKhTRPA1, HEKhTRPM8:CFP, HEKrTRPV1:YFP) were
obtained by a limiting dilution method as described recently
(Hellwig et al., 2004; Urban et al., 2012). All cells were grown
at 37°C in a humidified atmosphere containing 5% CO2.
Unless otherwise stated, cells were seeded 24 h prior to the
experiments on poly-L-lysine-coated coverslips.
DRG neuron preparation
Adult C57BL6/N mice, bred and kept at the local animal care
facility (Uniklinikum des Saarlandes, Homburg, Germany)
were killed by an overdose of i.p. urethane (25% in 0.9% NaCl
solution). Mice were opened from the dorsal side, and the
spinal cord was carefully exposed. The spinal cord was
then gently removed; and DRG from all cervical, thoracic
and lumbar segments were obtained. Ganglia were digested
for 15 min at 37°C in an enzyme solution containing
0.1 mg·mL-1 trypsin (Sigma-Aldrich, Deisenhofen, Germany),
and 44.4 mg·mL-1 liberase DH (Roche, Mannheim, Germany),
dissolved DMEM in (Gibco; Invitrogen). After repeated tritu-
ration with a 1 mL pipette, the digestion was stopped by
adding 100 mL FCS; the cell suspension was centrifuged
(3.5 min at 670 g) and resuspended in DMEM medium, sup-
plemented with 10% FCS, 100 units·mL-1 penicillin, and
0.1 mg·mL-1 streptomycin. Subsequently, droplets of cell sus-
pension were plated on poly-D-lysine (1 mg·mL-1; Sigma-
Aldrich)-coated coverslips, placed in a culture dish and left to
adhere for at least 1 h in an incubator (37°C, 5% CO2). The
culture dish was then filled with growth medium. All experi-
ments were performed within 36 h after preparation.
To obtain rat DRG neurones, 8 week-old Wistar rats were
killed by an overdose of CO2. The preparation of DRG neu-
rones was performed as described above. For patch clamp
measurements, NGF (30 ng·mL-1; Sigma-Aldrich) was added
to the medium. Wistar rats (Janvier, Saint Berthevin Cedex,
France) were housed under a 12 h light–dark cycle and
allowed access to laboratory animal feed and water ad libitum.
All studies involving animals are reported in accordance with
the ARRIVE guidelines for reporting experiments involving
animals (Kilkenny et al., 2010; McGrath et al., 2010). All
experimental procedures involving animals were approved by
the Committee on Animal Care and Use of the local govern-
mental body. Procedures were optimized to reduce the
number of animals and their suffering, according to the regu-
lations of the German Animal Welfare Act. A total number of
nine animals (two mice and seven rats) were used in experi-
ments described here.
Cell transfection
HEK293 cells were transiently transfected with a bi-cistronic
plasmid encoding Myc-tagged TRPM1 and enhanced green
fluorescent protein as previously described (Lambert et al.,
BJP I Straub et al.
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2011). The Polyfect transfection reagent (Qiagen, Hilden,
Germany) was used according to the instructions of the
manufacturer. One day after the transfection, cells were split
and reseeded at a reduced density. Cells were used for experi-
ments 36 to 72 h after the transfection. For heat activation of
TRPM3, HEK293 cells were transiently transfected with a
plasmid encoding TRPM3a2-GFP. Transfection was per-
formed with FugeneHD (Promega, Mannheim, Germany) and
48 h after transfection, cells were split and reseeded on poly-
L-lysine-coated coverslips.
Intracellular Ca2+ analysis in cell suspensions
All fluorometric assays in cell suspensions were performed at
room temperature in a 384-well microtitre plate format. For
detailed information, see Norenberg et al. (2011). Shortly,
HEK293 cells stably expressing TRPM3 were incubated with
Fluo-4/AM (4 mM; Molecular Probes, Invitrogen) for 30 min
at 37°C, washed and resuspended in HEPES-buffered solution
(HBS) buffer, containing 135 mM NaCl, 6 mM KCl, 1 mM
CaCl2, 1 mM MgCl2, 5.5 mM D-glucose, and 10 mM HEPES
adjusted to pH 7.4 with NaOH. For the primary screening,
wells were prefilled with individual compounds of a Spec-
trum Collection compound library (MicroSource Discovery
Systems, Gaylordsville, CT) at a final concentration of 20 mM.
Measurement was executed with a filter-based plate reader
device (Polastar Omega, BMG Labtech, Offenburg, Germany),
applying 485/10- and 520/20-nm band pass filters. After
recording a baseline of 160 s (10 cycles), PregS 35 mM, final
concentration, was injected into each well; and fluorescence
intensities were followed for 10 min after agonist injection.
To obtain concentration–response functions, various concen-
trations of the blocking compounds were pre-incubated for
10–15 min, and data were subjected to nonlinear curve fitting
applying a four-parameter Hill equation (Emin, Emax, IC50 and
Hill coefficient).
Measurements of agonistic properties of the compounds
were performed using a custom-made fluorescence plate
imaging device built into a robotic liquid handling station
(Freedom Evo 150, Tecan, Switzerland). The plate imaging
device comprised a 460-nm LED array, filtered with a 475 nm
short-pass filter (DT-blue, Optic Balzers, Oerlikon, Switzer-
land) and a cooled CCD camera (Coolsnap FX, Photometrics,
Tucson, AZ), equipped with a Xenon 0.95/25 C-mount lens
(Schneider Kreuznach, Bad Kreuznach, Germany), and a
515 nm long-pass filter (Y515-Di, Fujifilm, Tokyo, Japan). The
imaging was controlled with the MicroManager software
(Edelstein et al., 2010), and fluorescence intensities were
quantified over single wells, corrected for background signals
and expressed as F/F0, using ImageJ (Abramoff et al., 2004).
Single-cell calcium measurement
Transfected HEK293 cells attached to coverslips were loaded
with 5 mM Fura-2/AM (Biotium, Hayward, CA, USA) for
30 min at room temperature or, in the case of DRG neurons,
at 37°C. Coverslips were mounted in a recording chamber
(Warner Instruments, Hamden, CT, USA) and superfused with
the aid of a computer-controlled valve bench (ALA Scientific,
Farmingdale, NY, USA). For the measurements in mouse DRG
neurones, we used the same extracellular solution as for
whole-cell patch clamp measurements (see below). For meas-
urement of transfected HEK293 cells, the bath solution con-
tained 3 mM glucose and 7 mM mannitol instead of 10 mM
glucose. Images were captured at alternating excitation wave-
lengths of 340 and 380 nm with a 10¥ SFluor objective
(Nikon, Düsseldorf, Germany) and a cooled CCD camera
(QImaging, Surrey, Canada). Background subtraction and
ratio calculation were performed with ImageJ utilizing a
modified version of the ‘ratio-plus’ plugin.
For single-cell [Ca2+]i measurement in rat DRG neurones,
coverslips were mounted on a monochromator-equipped
(Polychrome, TILL-Photonic) inverted epifluorescence micro-
scope (Carl Zeiss, Jena; 10¥/0.5 Fluar objective), and super-
fused with HBS buffer. Detection and calibration of the
calcium concentration was performed with a spectral unmix-
ing method as described earlier (Lenz et al., 2002). All meas-
urements were performed at room temperature.
Whole-cell patch clamp measurements
Standard electrophysiology methods were used. All measure-
ments were performed at room temperature, expect for tem-
perature activation of TRPM3, using an Axopatch 200B
amplifier with a Digidata 1200 digitizer (Axon CNS, Molecu-
lar Devices, Sunnyvale, CA, USA) under the control of the
Pclamp 9 software (Molecular Devices). Voltage ramps (from
-113 to +87 mV, 1 mV·ms-1) were applied every second from
a holding potential of -13 mV. The intracellular solution
contained 80 mM Cs-aspartate, 45 mM CsCl, 4 mM Na2ATP
or TRIS2-ATP, 10 mM HEPES, 10 mM BAPTA, pH 7.2 adjusted
with CsOH. The osmolarity was 300–315 mosm. The extra-
cellular solution used contained 145 mM NaCl, 3 mM KCl,
10 mM CsCl, 2 mM CaCl2, 2 mM MgCl2, 10 mM HEPES,
10 mM D-glucose, pH 7.4 adjusted with NaOH. The liquid
junction potential of approximately 13 mV between the bath
solution and the pipette solution (calculated with Clampex,
Axon Instruments, Molecular Devices) was corrected. The
sampling rate was 5 kHz in standard whole-cell measure-
ments. During fast application of naringenin, the sampling
rate was 20 kHz. Modulators were applied via a SF-77B Per-
fusion Fast Step system (Warner Instruments). Current decay
kinetics were calculated with Clampfit 9.2 (Molecular
Devices), using a biexponential fitting. For heat activation of
TRPM3, the bath solution was cooled to 17–20°C under
control conditions. To activate and block TRPM3, pre-cooled
solutions were heated to 37–40°C with an inline solution
heater (Warner Instruments) under control of a TC-324B
Temperature Controller (Warner Instruments). To monitor
the actual temperature of the bath solution, a thermistor
electrode was situated in the vicinity of the patched cell, and
the temperature was logged during the measurement with the
Pclamp 9 software. For recordings in DRG neurones, the
extracellular solution contained 140 mM NaCl, 2 mM MgCl2,
4 mM KCl, 0.5 mM lidocain, 10 mM TRIS (pH 7.4 with HCl),
and the pipette solution contained 140 mM CsCl, 0.6 mM
MgCl2, 1 mM EGTA, 10 mM HEPES, 5 mM TEA (pH 7.2 with
CsOH). Although lidocain activates recombinant rTRPV1
with an EC50 of about 12 mM (Leffler et al., 2008), the con-
centration we used to block voltage-dependent sodium chan-
nels should not strongly influence TRPV1.
Stock solutions and drugs
All modulators were dissolved in DMSO. The concentration
of stock solutions was chosen in such a way that the DMSO
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concentration in the final solution never exceeded 0.14% at
the highest concentration of the respective modulator and
further reduced by serial dilution of the compounds. PregS,
naringenin, hesperetin, eriodictyol and ononetin were pur-
chased from Sigma-Aldrich.
Statistical analysis
All error bars represent the SEM. The number of cells analysed
in each experiment is indicated in the figure legends. To test
for statistically significant differences, we used ANOVA with the
Tukey’s post test. In the figures, one star indicates P < 0.05,
two stars indicate P < 0.01, three stars indicate P < 0.001.
Results
Screening for compounds that modulate
TRPM3 channel activity
To identify compounds that exert a biological activity to
modulate TRPM3, we performed a medium throughput
screen. To this end, the Spectrum Collection compound
library, comprising 2000 drugs, drug-like molecules, natural
compounds or toxins, was used at a final concentration of
20 mM. HEK293 cells stably expressing mTRPM3 (HEKmTRPM3)
were loaded with the fluorescent calcium indicator dye
Fluo-4, dispensed into 384-well plates, and PregS-induced
calcium entry was detected. As a result of the primary screen,
we identified three compounds that completely blocked the
PregS-induced calcium entry (Figure 1A–C). Furthermore, we
confirmed the previously identified TRPM3 channel-blocking
properties of the fenamates tolfenamic acid and mefenamic
acid (Klose et al., 2011). The three newly identified blocking
compounds belong to a class of plant secondary metabolites.
The flavonoids naringenin and hesperetin are contained in
grapefruits and oranges respectively. Ononetin is a deoxyben-
zoin that has originally been synthesized from Ononis
spinosa-derived isoflavanones, but may also be obtained from
fabaceae. In grapefruit, a major fraction of naringenin is con-
jugated with the disaccharide neohesperidose. This glycoside
is referred to as naringin, and accounts for the bitter taste of
grapefruit (Manach et al., 2004). Interestingly, neither nar-
ingin nor hesperidin, the glycoside of hesperetin, blocked
TRPM3 (Figure 1A,B).
Hit verification in a secondary screen with freshly dis-
solved compounds confirmed the ability of the citrus fruit
flavanones and ononetin to block TRPM3. Furthermore, we
found that eriodictyol, which is found in lemons or formed
by hepatic metabolism of naringenin and hesperetin (Brein-
holt et al., 2002), completely blocked the PregS-induced Ca2+
entry in HEKmTRPM3 cells when pre-incubated at a concentra-
tion of 20 mM (Figure 1D,E).
Concentration dependence and
electrophysiological properties of the
flavonoid-induced TRPM3 block
To evaluate the potency of the flavonoids to block TRPM3,
we used a fluorometric Ca2+ assay to obtain concentration-
response curves. HEKmTRPM3 cells were incubated with different
concentrations of the test compounds, and PregS-induced
calcium entry was measured. The applied PregS concentration
of 35 mM is higher than the reported EC50 of 12 and 23 mM for
TRPM3 inward and outward currents (Wagner et al., 2008) but
is not yet saturating. Naringenin and hesperetin displayed a
potent block with IC50 values of 0.5 0.07 mM (Figure 2A) and
2.0  0.1 mM (Figure 2B) respectively. Ononetin displayed an
IC50 of 0.3  0.03 mM (Figure 2C) and eriodictyol blocked
TRPM3 with an IC50 of 1.0  0.07 mM (Figure 2D). The Hill
coefficients ranged between 1.4 and 2.2 for the investigated
compounds (see Figure 2).
To further characterize the new blockers, we performed
whole-cell patch clamp measurements in the presence of
naringenin (Figure 3) and ononetin (Figure 4). The onset of
the naringenin-induced block was fast, but a complete block
was only achieved after a few seconds (Figure 3A). Wash-out
of naringenin allowed a reactivation of TRPM3 channels with
PregS (Figure 3A). However, naringenin-blocked TRPM3 cur-
rents recovered only slowly after removal of the modulator
(Figure 3A). Applying I/V ramp protocols, we observed that
the naringenin-induced block is largely voltage-independent
(Figure 3B) and reversible. In order to more rapidly deliver the
compound to the patched cell, we performed some experi-
ments with a fast application system and supramaximally
effective concentrations of naringenin (Figure 3C). A biexpo-
nential fit of the decaying current kinetic revealed fast and
slow t-values of 291 and 2370 ms. The major component of
the current (77%) decayed with tfast, and only 23% of the
current was blocked with a tslow (Figure 3C). Interestingly,
naringenin exerted a slightly higher blocking potency in
whole-cell measurements compared with the calcium assay.
Electrophysiologically measured concentration–response
curves of naringenin showed that inward currents were more
potently blocked (IC50 = 0.27  0.04 mM) compared to the
outward currents (IC50 = 0.37  0.005 mM). Although the
potency of TRPM3 block displayed some voltage dependence,
both current components were naringenin-sensitive and
almost completely blocked at a concentration of 3 mM
(Figure S1).
The current decay after ononetin-induced block devel-
oped faster than the naringenin induced block of TRPM3,
and the block was rapidly reversible (Figure 4A). Comparable
to naringenin, ononetin blocked TRPM3 in a voltage-
independent fashion (Figure 4B). In electrophysiological
recordings, ononetin showed approximately the same
efficiency as previously found in Fluo-4 measurements. A
concentration of 0.3 mM ononetin blocked 62%  4% of
PregS-induced currents at -113 mV and 53% 4% at +87 mV,
and at a concentration of 3 mM, the currents were completely
abolished (Figure 4C).
To exclude that the blocking effect of naringenin and
ononetin is restricted to PregS activation of TRPM3, we per-
formed whole-cell measurements with nifedipine as activator
of TRPM3 (Wagner et al., 2008). As shown in supplemental
Figure 2, nifedipine (50 mM)-induced TRPM3 currents were
concentration-dependently (tested concentrations: 1 mM and
3 mM) blocked by naringenin or ononetin.
Since heat may be a physiological activator of TRPM3, we
tested if the newly identified compounds also block heat-
induced TRPM3 currents. HEK293 cells transiently trans-
fected with TRPM3a2 showed small outward and inward
currents after raising the bath solution to temperatures above
37°C (Figure 5). These currents were partially blocked by
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5 mM naringenin and ononetin (Figure 5A). About 80% of the
heat-dependent outward currents were blocked by narin-
genin or ononetin, whereas only 40–60% of the inward cur-
rents were blocked (Figure 5C). Hesperetin (10 mM) and
eriodictyol (20 mM) also partially blocked heat-induced acti-
vation of TRPM3 (Figure 5D,E). Of note, raising the tempera-
ture in measurements with untransfected parental HEK cells
also gave rise to substantial inward and outward currents
(Figure 5F), In contrast to transfected HEK293 cells, ononetin
and naringenin did not diminish neither inward nor outward
currents in the untransfected parental HEK293 cells. We con-
clude that background currents that are not sensitive to
TRPM3 blockers may cause an underestimation of the effi-
ciency of blocker effects on the heat-activated TRPM3.
Figure 1
Identification of TRPM3 channel-blocking compounds. Fluo4-loaded HEK293 cells stably expressing TRPM3 (HEKmTRPM3) were incubated with
single compounds (20 mM) of the Spectrum Collection, and fluorescence intensities were detected during injection of the TRPM3 activator PregS.
(A–D) Examples of calcium entry traces extracted from a single 384-well plate measurement. Light grey trace represents a DMSO control (A–D).
Black trace: (A) hesperetin, (B) naringenin, (C) ononetin and (D) eriodictyol. Dark grey: (A) hesperidin and (B) naringin. (E) Chemical structures
of verified hits naringenin, hesperetin, ononetin and eriodictyol as well as the flavonoid glycoside hesperedin and naringin.
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Biophysical properties of TRPM3 block by
naringenin and ononetin
To more precisely specify the blocking mechanism we tested
from which side of the plasma membrane naringenin and
ononetin act on TRPM3 channels by adding the substances
to the intracellular solution. Even at a concentration of
3 mM, intracellularly applied ononetin was unable to block
PregS-induced currents in HEKmTRPM3 cells, whereas addition
of the TRPM3 blocker to the bath solution was still effective
(Figure 6A). Naringenin showed similar results, however at
concentrations above 0.6 mM in the pipette, gigaseals were
frequently lost during whole-cell patch-clamp measure-
ments (Figure 6D). Although this concentration is sufficient
to almost completely block PregS-induced currents when
added from the outside (Figure 3C), there was no overt
decrease in the current densities after PregS-induced TRPM3
channel activation in cells that were patched with narin-
genin in the pipette solution. These findings strongly hint
at an extracellularly accessible binding site for naringenin
and ononetin.
Electrophysiological measurements showed differences in
the blocking behaviour of naringenin and ononetin. Whereas
ononetin showed a fast and rapidly reversible block, the
naringenin-induced block recovered with a slower off-rate.
Together with the fact that PregS is an activator of TRPM3
channels from the extracellular side (Wagner et al., 2008),
these observations prompted us to investigate whether the
blockers may interfere with the activator binding. To this
end, TRPM3-expressing cells were incubated with naringenin
or ononetin, and calcium entry was measured after activation
of TRPM3 with different PregS concentrations (Figure 7).
Lowering the PregS concentration did not lead to significant
changes of the IC50 values of ononetin and naringenin.
Increasing the concentration of PregS to 100 mM, however,
shifted the IC50 of ononetin to a higher concentration
(1.9 mM) (Figure 7A); whereas the IC50 of naringenin
remained almost unaffected (Figure 7B).
Specificity of TRPM3 channel blockers
To examine the specificity of the blockers, we first investi-
gated the ability of naringenin and ononetin to block the
most closely related channel TRPM1. Like TRPM3, TRPM1
can be activated by PregS (Lambert et al., 2011). At a concen-
tration of 10 mM, naringenin did not exert a strong inhibition
of the PregS-mediated calcium entry in HEK293 cells that
express TRPM1 (Figure 8A). In contrast to naringenin, 10 mM
ononetin partially attenuated the PregS-induced calcium
responses in TRPM1-expressing cells by about 50%
(Figure 8B). In agreement with Lambert et al., TRPM1 chan-
nels were almost completely and reversibly blocked by
100 mM Zn2+ in contrast to TRPM3 channels (Wagner et al.,
2010).
Figure 2
Concentration–response curves of TRPM3-blocking compounds. HEKmTRPM3 cell suspensions were incubated with various inhibitor concentrations
as indicated. Fluorescence intensities were measured during PregS-induced activation of TRPM3. TRPM3 activation without an inhibitor was set
as 100% and fluorescence intensities containing inhibitors were normalized to this value. (A–D) Concentration–response curves of naringenin,
ononetin, hesperetin and eriodictyol are shown. Each data point represents at least six independent experiments for naringenin and ononetin and
four independent experiments for hesperetin and eriodictyol with duplicates each. Shown are mean values and SEM. IC50 values and Hill
coefficients (n) were obtained by non-linear curve fitting, applying a four-parameter Hill equation.
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Since an involvement of TRPM3 in thermal nociception
has been shown, we further investigated the ability of the
flavanones hesperetin, naringenin and eriodictyol as well as
the deoxybenzoin ononetin to block sensory TRP channels
that are expressed in DRG neurones, including TRPA1,
TRPM8 and TRPV1. Naringenin did not have an influence on
TRPA1, whereas at very high concentrations, naringenin
exerted a partial inhibition of TRPV1 (Figure 9A). Naringenin
activated TRPM8 (Figure 9E) and prevented a subsequent acti-
vation by menthol (Figure S3A). Interestingly, menthol-
induced currents in HEK cells expressing TRPM8 were
blocked after an additional perfusion of the cells with narin-
genin (Figure S3B). However, further investigations are
needed to clarify the complex mechanism of naringenin to
block and activate TRPM8.
Hesperetin and eriodictyol neither blocked nor activated
any tested TRP ion channels other than TRPM3 when applied
in concentrations up to 50 mM (Figure 9B,D). Ononetin, the
most potent TRPM3 channel blocker, activated TRPA1 in
fluorometric measurements (Figure 9F) but had no overt
influence on TRPM8 or TRPV1 at concentrations up to
100 mM (Figure 9C). Since many compounds that promote
TRPA1 activation in fluorometric Ca2+ assays act in a light-
dependent fashion (Hill and Schaefer, 2009), we reassessed
Figure 3
Electrophysiological properties of naringenin-mediated TRPM3 block. (A) Representative recordings of whole-cell currents in HEKmTRPM3 cells
induced by 35 mM PregS and reversibly blocked with 3 mM naringenin. Data are extracted from voltage ramps and depict the current at 87 mV
(upper trace) and -113 mV (lower trace). Dotted line: zero current level. (B) To assess the blocker activity in HEKmTRPM3 at different potentials, slow
ramps (1 mV·ms-1) ranging from -100 to 50 mV were applied in the presence of PregS before (1), during (2) and after (3) addition of 3 mM
naringenin. (C) Representative whole-cell recording, a HEKmTRPM3 cell clamped at -83 mV, showing currents in response to 35 mM PregS and
currents blocked with 10 mM naringenin. Naringenin was acutely applied with a fast perfusion system. Insert: superposition of the decaying phase
of TRPM3 currents and a biexponential fit of the data. (D) Statistical analysis of 6–12 independent experiments performed as shown in (A), but
with various concentrations of naringenin. Dashed line: Level of background conductivity in the absence of PregS and naringenin. Statistically
significant differences of TRPM3 activation with PregS and block with naringenin are indicated as asterisks.
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the TRPA1 activation in electrophysiological experiments.
Whole-cell measurement of TRPA1 currents did not show
significant current increases after challenging the cells with
ononetin at concentrations up to 30 mM (Figure S4A). We
further tested if the activation of TRPA1 by ononetin involves
oxidative intermediates. Indeed, [Ca2+]i responses in TRPA1
cells stimulated with low ononetin concentrations (6.25 mM)
were strongly attenuated in the presence of the reducing
agent DTT (10 mM, applied to the bath solution; Figure S4C–
E). At higher ononetin concentrations of 12.5–25 mM, DTT
exerted a lower or no inhibitory activity. By contrast, DTT
supplementation did not attenuate the block of TRPM3 by
ononetin. We conclude that oxidative intermediates of onon-
etin may be involved in activating TRPA1, but not in the
block of TRPM3 by ononetin.
Next, we tested if the TRPM3-blocking compounds inter-
fere with the endogenously expressed TRPM7 in HEK293
cells. Since external divalent cations are permanent blockers
of TRPM7, switching to a bath solution lacking Ca2+ and Mg2+
gives rise to large inward currents (Nadler et al., 2001).
Neither TRPM7-dependent inward nor outward currents were
influenced by ononetin, hesperetin or eriodictyol (20 mM
each; Figure S5A). Naringenin partially blocked TRPM7 cur-
rents at a concentration of 20 mM (see Figure S5A,B).
Efficiency of naringenin and ononetin to
block endogenous TRPM3 channels in
isolated DRG neurones
We used mouse DRG neurones to investigate the influence
of naringenin and ononetin on endogenously expressed
TRPM3. Neither ononetin nor naringenin (5 mM each) had an
influence on DRG neurones without a previous activation
of TRPM3 by PregS (Figure 10A,D), whereas PregS-induced
calcium entry was blocked by naringenin as well as ononetin
(Figure 10B,E). The block of ononetin and naringenin on
endogenously expressed TRPM3 was reversible, according to
the measurements in HEKmTRPM3 cells. A significant fraction of
calcium entry reappeared upon removal of naringenin or
ononetin in the continuous presence of PregS (Figure 10B,E).
Next, we investigated if flavonoids are able to block
TRPM3 that is endogenously expressed in rat DRG neu-
rones. First, we detected mRNA of TRPM3 in freshly isolated
rat DRG neurones via RT-PCR (data not shown). Single cell
[Ca2+]i measurements revealed PregS-inducible, TRPM3-like
signals that were blocked by naringenin (data not shown) or
ononetin (Figure 11A). Of note, the KCl-triggered activation
of voltage-gated Ca2+ channels, identifying neuronal cells in
the cultures, was not significantly affected by eriodictyol,
naringenin and ononetin, reaching steady-state [Ca2+]i con-
centrations of 698  45 nM (n = 10), 626  130 nM (n = 6)
and 700  76 nM (n = 6) respectively. We further showed
that eriodictyol blocked PregS-induced calcium entry in rat
DRG neurones (Figure 11B). From 165 measured DRG neu-
rones, 90 responded to PregS of which 39 also showed a
response to 2 mM capsaicin. These data indicate that rat
DRG neurones also functionally express Ca2+-permeable
TRPM3 isoforms.
Eriodictyol has been proposed as a blocker of TRPV1 with
antioxidant activity (Rossato et al., 2011). In our hands, erio-
dictyol neither blocked capsaicin induced calcium entry in
HEK293 cells stably expressing rat TRPV1 (Figure 9D) nor in
freshly isolated rat DRG neurones (Figure 11B). Overall, 114
of 165 DRG neurones (69%) were still sensitive to capsaicin,
although the neurones were treated with 20 mM eriodictyol.
To specify the influence of eriodictyol on TRPV1, we per-
formed whole-cell measurements of freshly isolated rat DRG
neurones. Capsaicin-induced inward currents in DRG neu-
rones were not diminished after perfusion with 20 mM erio-
dictyol (Figure 11C).
Discussion
In this study, we identified citrus fruit flavanone aglycones as
potent and selective TRPM3 channel blockers. With IC50
values in the upper nanomolar (naringenin and ononetin) or
low micromolar range (hesperetin and eriodictyol), these
natural compounds completely and reversibly abrogate Ca2+
Figure 4
Electrophysiological properties of ononetin-induced TRPM3 block. (A) Whole-cell recording from a HEKmTRPM3 cell during stimulation with 35 mM
PregS and acute addition of 3 mM ononetin. Data are extracted from voltage ramps and depict current amplitudes at 87 mV (upper trace) and
-113 mV (lower trace); dotted line: zero current level. (B) I/V curve of PregS-activated TRPM3 currents before (1), during (2) and after (3) addition
of 3 mM ononetin. (C) Statistical analysis of peak current densities in resting HEKmTRPM3 cells after addition of 35 mM PregS and different
concentrations of ononetin. Data represent means and SEM of at least 11–16 independent experiments.
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entry and ionic currents through recombinantly expressed
TRPM3a2 and block the pregnenolone sulphate-inducible
Ca2+ entry in primary cultures of mouse or rat DRG neurones,
indicating biological activity towards endogenously ex-
pressed TRPM3.
Sensory TRP channels are influenced by a large and still
growing number of natural compounds, thereby mediating
thermal, gustatory, odorant or eventually painful sensations
(Vriens et al., 2008). Flavonoids comprise the most common
group of plant-derived polyphenolic compounds in the
human diet. Flavanones, like naringenin and hesperetin, are
a class of polyphenols that is almost exclusively contained in
citrus fruits. Epidemiological and animal studies point to a
possible biological activity of citrus flavonoids that might be
advantageous in diseased states, such as cardiovascular disor-
ders or cancer (for review see Benavente-Garcia and Castillo,
2008). In contrast to agonistic compounds that mimic the
sensory quality of the respective TRP channel, such as a
burning sensation induced by capsaicin via TRPV1 activation,
chemically defined blockers do not interfere with the channel
activity in the absence of an activator. Thus, it is not unex-
pected that, thus far, no specific sensation has been linked to
the TRPM3-blocking agents. The characteristic taste of nar-
ingin or hesperidin is restricted to the respective glycoside
Figure 5
Heat-induced TRPM3 currents were partially blocked by TRPM3 blocker, whereas currents in non-transfected HEK293 cells were not affected by
TRPM3-blocking compounds. (A) Representative whole-cell recording from a HEK293 cell transiently transfected with TRPM3a2. Elevation of the
temperature of the bath solution elicited outward and inward currents (measured at 87 and -113 mV, respectively) that could be partially blocked
by ononetin (10 mM) and naringenin (10 mM). (B) I/V curve of heat-activated (about 38°C) TRPM3 currents before (2) and during superfusion with
10 mM ononetin (3) or naringenin (4). (C) Aggregated data of five to six independent measurements. (D,E) Representative whole-cell measure-
ments performed as shown in panel A, but with 10 mM hesperetin (D) or 20 mM eriodictyol (E). (F) Control experiments in non-transfected
parental HEK293 cells reveal that heat-activated background currents are unaffected by superfusion with either naringenin or ononetin (10 mM
each). In the presence of NS8593 (30 mM), a blocker of small conductance K+ channels (SK1-SK3) and TRPM7 channels, heat-activated outward
currents were partially inhibited.
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forms, but absent in the cognate TRPM3-blocking aglycones,
thereby ruling out that TRPM3 is involved in sensing the
bitter taste of grapefruit.
In the intestine, the flavanone glycosides hesperidin and
naringin are deglycosylated to the membrane-permeable
aglycones, and are then absorbed (Felgines et al., 2000).
Specifically, the rutinose or neohesperidose moieties are
rapidly hydrolysed by enzymes of bacterial origin, such as
a-rhamnosidase and b-glucosidases (Fuhr and Kummert,
1995). Considering that the glycosides did not exhibit
TRPM3-blocking properties, the intestinal processing to their
cognate aglycones represents a bioactivation pathway.
Until recently, naringenin has been thought to cause
food-drug interactions by inhibiting cytochrome P450
enzymes. However, in vitro studies have shown that naringin
and naringenin attenuate CYP3A4 activity by about 50%
only when applied at concentrations of 200 mM (Bailey et al.,
2000). Meanwhile, the inhibitory effect of grapefruit juice on
Figure 6
Binding site of naringenin and ononetin is accessible from the extracellular side. (A) and (D), representative whole-cell recording from a HEKmTRPM3
cell internally perfused with 3 mM ononetin (A) or 0.6 mM naringenin (D). An additional extracellular application of 35 mM PregS is still able to
activate TRPM3 induced currents, which were reversibly blocked by 1 mM ononetin (A) or 1 mM naringenin (D) when added to the bath solution
in the continued presence of PregS. Data are extracted from voltage ramps and depict the current at 87 mV (upper trace) and -100 mV (lower
trace). Dashed lines: zero current level. Slow voltage ramps (1 mV·ms-1) were applied, in the presence of 3 mM ononetin (B) or 0.6 mM naringenin
(E) in the pipette, to PregS-stimulated HEKmTRPM3 before (1), during (2) and after (3) extracellular perfusion with 1 mM ononetin (B) or 1 mM
naringenin (E). (C and F) Statistical analysis of experiments indicated in panel A or D. Data represent mean values and SEM of at least seven
independent experiments for panels A–C and six independent experiments for panels D and E.
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CYP3A4 has been attributed to more potently inhibiting con-
stituents, such as the furanocoumarins bergamottin and ber-
gapten (Hanley et al., 2011). Nonetheless, naringenin and
hesperetin are substrates of CYP-mediated hydroxylation,
resulting in the formation of the common metabolite erio-
dictyol. Since both the CYP substrates as well as their product
display a similar IC50, and since the kinetics of the block is fast
and reversible, we conclude that the biological activity to
block TRPM3 is neither related to CYP activity, nor to its
inhibition.
With an IC50 of 0.5 mM, naringenin is the most potent
TRPM3-blocking flavanone. The additional hydroxyl group at
the C3′ atom found in hesperetin and eriodictyol diminishes
the potency of the TRPM3 block to low micromolar concen-
trations. Despite a slightly lower potency, however, the C3′
hydroxylation increased the selectivity for TRPM3. Neither
eriodictyol nor hesperetin discernibly influenced the sensory
TRP ion channels TRPV1, TRPM8, TRPA1. By contrast, higher
concentrations of naringenin modulated HEK293 cells stably
expressing TRPM8 in a complex fashion that was reminiscent
of a partial agonism, followed by deactivation of TRPM8.
With respect to TRPM1, the closest relative of TRPM3, we
found that 10 mM ononetin, but not naringenin inhibited
PregS-induced [Ca2+]i signals that are mediated by TRPM1 by
about 50%. Considering that the IC50 of ononetin to block
TRPM3 is 0.3 mM, the selectivity of ononetin is still 30-fold
and can be employed to differentiate between these channels.
With an IC50 of 300 nM, the deoxybenzoin ononetin is, to
our knowledge, the most potent TRPM3 blocker that has been
identified so far. Ononetin is a still poorly characterized com-
pound. Ononetin and other deoxybenzoins have been shown
to confer antioxidant properties and, at concentrations above
10 mM, to inhibit tyrosinases (Ng et al., 2009). Since the
ononetin-induced activation of TRPA1 is partially sensitive to
Figure 7
Naringenin and ononetin show different blocking behaviour. A HEKmTRPM3 cell suspension was loaded with Fluo-4 and exposed to different
concentrations of ononetin (A) and naringenin (B). Calcium entry was stimulated with two different concentrations of PregS to obtain
concentration–response curves. (A) Concentration–response curves of ononetin in the presence of 17.5 mM PregS and in the presence of 100 mM
PregS. (B) Concentration–response curves of naringenin-induced TRPM3 channel block in the presence of 17.5 mM PregS and in the presence of
100 mM PregS. Shown are means and SEM of at least three to five different experiments in duplicates each. IC50 values and Hill coefficients (n)
were obtained by non-linear curve fitting, applying a four-parameter Hill plot.
Figure 8
Naringenin affects Ca2+ entry through TRPM1only weakly and ononetin partially blocks TRPM1 channels. Single cell calcium imaging experiments
with HEK293 cells transiently transfected with cDNA plasmids encoding TRPM1 and loaded with the fluorometric Ca2+ indicator fura 2. TRPM1
was activated with 50 mM PregS alone and in the presence of 10 mM naringenin (n = 44) (A) or 10 mM ononetin (n = 50) (B), followed by
application of PregS alone and in combination with 100 mM ZnCl2. Shown are means and SEM of at least four to six independent imaging
experiments.
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the reducing agent DTT, oxidated ononetin intermediates
may be involved. The block of TRPM3, however, requires very
low ononetin concentrations, develops within a few seconds
and is not counteracted by 10 mM DTT, arguing against a
necessity of oxidation for TRPM3 block. Ononetin can be
produced from the isoflavone ononin (Hlasiwetz, 1855), an
isoflavone glycoside that is not only found in the name-
giving plant O. spinosa but also contained in edible plants,
such as soy bean and clover. Owing to their structural simi-
larity to estradiol and transactivation of the estrogen recep-
tors ERa and ERb, isoflavones are regarded as phytoestrogens
(Cederroth and Nef, 2009). A structural relationship between
ononetin and steroids may provide the structural basis of a
competitive interference between ononetin and the neuros-
teroid PregS with regard to TRPM3 binding. Indeed, the
blocker sensitivity was attenuated when exposing TRPM3 to
higher PregS concentrations (see Figure 7). However, both
competitive binding to the activator site or allosteric modu-
lation that mutually impedes on the ligand-binding proper-
ties may explain these effects.
Of note, the TRPM3 gene transcripts are spliced into
several splice variants that either bear a Ca2+-permeable pore
(e.g. the a2 variant) or to an a1 variant whose pore is selective
for monovalent cations and not activated by PregS (Oberwin-
kler et al., 2005). Since activators of the a1 variant are still
unknown, and since fluorometric Ca2+ assays are inapplicable
Figure 9
Effects of TRPM3 channel blockers on other sensory TRP channels. HEK293 cells stably expressing the indicated TRP channels were preincubated
with naringenin (A), hesperetin (B), ononetin (C) or eriodictyol (D); and activation of the respective channels was followed by measuring increases
in the fluorescence intensity of intracellularly loaded Fluo-4, or in HEKrTRPV1:YFP cells, by monitoring the Ca2+ influx-mediated intracellular
acidification, causing a decrease in the fluorescence intensity of co-expressed YFP (Hellwig et al., 2004). The respective activators are 2 mM
capsaicin for TRPV1, 30 mM AITC for TRPA1 and 300 mM menthol for TRPM8. Data represent mean and SEM of three to six different experiments,
performed in duplicate each. Grey curves indicate the Hill fit of TRPM3 block by the indicated compounds. (E) Naringenin-induced Ca2+ entry in
HEKhTRPM8:CFP and (F) ononetin-induced calcium entry in HEKhTRPA1 cells.
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with this isoform, we did not assess the effects of ononetin or
flavanones on TRPM3a1. In addition, fluorometric assays in
DRG neurones relied on a PregS-triggered Ca2+ entry and,
thus, most likely reflect splice variants that share the a2 pore
conformation.
Since naringenin and ononetin also blocked the TRPM3
activation by nifedipine, an activator that is chemically unre-
lated to PregS, a competitive mode of action appears unlikely.
In addition, heat-mediated TRPM3 activation is also strongly
blocked by both compounds. Thus, naringenin and ononetin
induced block is not restricted to PregS activation of TRPM3.
In this study, we provide evidence for a binding mode
that involves the extracellularly accessible moieties of the
channel protein and exhibits a slight voltage dependence
in favour of blocking the physiologically more relevant
inward current component and a reversible mode of action.
A more thorough electrophysiological characterization,
including a detailed kinetic analysis, the assessment of
use dependence, and profiling of single channel properties
in the presence of the blockers, may provide additional
insights in the mechanism of TRPM3 block by these natural
compounds.
Another still unresolved question relates to the localiza-
tion of the binding site of the flavanones and deoxybenzoins
on TRPM3. Electrophysiological data obtained with intracel-
lularly perfused modulators demonstrated that TRPM3 was
still activated by PregS, and that the same modulator only
blocked this conductance when added to the bath solution.
Although the most common interpretation would be that the
binding site is accessible from the extracellular space, the
unrestricted membrane permeability of the aglycones may
result in a rapid intracellular dilution of the TRPM3 modulator.
In addition, the insensitivity of TRPM3 to the glycosides is
likely to result from an inability of flavanone glycosides to
bind to TRPM3. An alternative explanation could be that
the more hydrophilic compound is largely membrane-
impermeable and might not reach an intracellular binding site
on TRPM3. Thus, more detailed analyses of the modulator-
binding properties and on the interference with the channel
gating will be addressed in future by electrophysiological
studies.
TRPM3 is expressed in nociceptive sensory neurones in
dorsal root and trigeminal ganglia, and its activation has been
linked to thermal pain. Specifically, TRPM3-/- mice show an
attenuated response to thermal nociceptive stimuli, an effect
that is maintained after induction of inflammatory hyperal-
gesia (Vriens et al., 2011). Here we show that naringenin as
well as ononetin block the PregS-induced Ca2+ entry in freshly
isolated neurones from mouse DRG. Besides DRG neurones
from mice, TRPM3-like responses were also found in PregS-
stimulated freshly isolated rat DRG neurones, and these
responses were blocked by eriodictyol. Rossato et al. (2011)
showed that eriodictyol is a potent blocker of TRPV1 with
analgesic effects on capsaicin-treated mice and complete Fre-
und’s adjuvant-induced thermal hyperalgesia. Astonishingly,
and in contrast to this report, we observed that eriodictyol is
Figure 10
PregS-evoked Ca2+ influx in mouse DRG neurones is reduced by naringenin or ononetin. (A,B) Example traces of single DRG neurones in calcium
imaging measurements. Freshly dissociated DRG neurones were loaded with Fura-2/AM, and fluorescence changes at 340 and 380 nm were
measured. DRG neurones were superfused with 5 mM naringenin alone (A) or simultaneously with 50 mM PregS that was applied longer than the
inhibitor (B). (C) Statistical analysis of data similar to those presented in (B). A total number of 70 DRG neurones were monitored in nine
microfluorometric imaging experiments to obtain these data. (D,E) Sample traces of single DRG neurones similar to panel A except 5 mM of
ononetin was applied alone (D) or simultaneously with PregS (applied longer than ononetin) (E). (F) Statistical analysis of experiments performed
in panel E. A total number of 163 neurones were analysed in eight imaging experiments. Bath solutions contained (20 mM) verapamil to suppress
voltage-gated calcium channel activity. Intact neurones were identified at the end of the experiment by applying 75 mM KCl in the absence of
verapamil (indicated by arrows).
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a potent blocker of TRPM3, but not of TRPV1. The inability of
eriodictyol to block the capsaicin-induced activation of rat
TRPV1 was tested in a recombinant expression system and
confirmed in freshly isolated rat DRG neurones. Since we
cannot confirm the TRPV1-blocking properties of eriodictyol,
one should consider the possibility that the thermal
hypoalgesia that has been observed by Rossato et al. may be
related to the block of TRPM3.
Due to the availability of pharmacokinetic and toxicologi-
cal data, flavanones such as naringenin may be applied in
vitro as well as in vivo studies. In mice, naringenin has an LD50
of more than 5 g·kg-1 (Ortiz-Andrade et al., 2008). Therefore,
a potential antinociceptive effect of citrus fruit flavanones
may be tested in vivo and might reveal a therapeutic potential
for analgesic treatment.
After consumption of grapefruit juice and orange juice,
plasma concentrations of naringenin and hesperetin may
reach low micromolar concentrations (Erlund et al., 2001).
Once resorbed, they undergo extensive phase 1 and phase 2
metabolization via hydroxylation, glucuronidation and sul-
fatation (Fuhr and Kummert, 1995). Thus, if citrus fruit
flavonoids exert promising pharmacodynamic properties, a
further compound optimization should be considered to
avoid a rapid modification. Alternatively, the modulators
might be applied topically, or the bioavailability and stability
of naringenin may be enhanced by complexation with
hydroxyl-b-cyclodextrin (Shulman et al., 2011).
In summary, we identified specific and potent blockers of
TRPM3 that can be used to investigate its function in vivo and
in vitro. Since the physiological functions of TRPM3 are still
not firmly established, we expect that acute TRPM3 modula-
tion with pharmacological modulators provides a useful and
validated cell-biological tool to study TRPM3 in vitro and in
vivo and to complement transgenic approaches. Furthermore,
if the involvement of TRPM3 in nociception could be
strengthened, TRPM3-blockers may offer a novel mode of
action for analgesic treatment.
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Eriodictyol blocks TRPM3, but not TRPV1 in rat DRG neurones. (A)
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shown in the upper panel. n.s., statistically not significant.
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Figure S1 Concentration–response curves of naringenin-
induced TRPM3 block. Whole-cell recordings of HEKmTRPM3
cells stimulated with 35 mM of PregS and blocked with differ-
ent concentration of naringenin were performed to obtain
concentration–response curves. To avoid that the rundown of
the channel is considered as block, an interpolated value
between before and after block was used to calculate the
percent of block. A time-matched activation of TRPM3
without naringenin was set as 100%, and measurements in
the presence of naringenin were normalized to this value.
(A) Representative recordings of whole-cell currents. Data are
extracted from voltage ramps and depict the current at 87 mV
(upper trace) and -113 mV (lower trace). Dotted line: zero
current level. (B–C) Concentration–response curves of
naringenin to block PregS-induced inward currents (B) and
outward currents (C). IC50 values and Hill coefficients (n) were
obtained by non-linear curve fitting, applying a four-
parameter Hill equation. Each data point represents SEM of
5–12 independent experiments.
Figure S2 Naringenin and ononetin block nifedipine-
induced TRPM3 currents in HEKmTRPM3 cells. (A) Whole-cell
recording from a HEKmTRPM3 cell stimulated with 50 mM nifed-
ipine and 35 mM PregS. And further nifedipine-induced
TRPM3 currents were blocked with either 1 or 3 mM of onon-
etin. Data are extracted from voltage ramps and depict
current amplitudes at 87 mV (upper trace) and -113 mM
(lower trace); dotted line: zero current level (B) IV curve of
PregS- (1) and nifedipine-activated TRPM3 currents (2) and
during an additional stimulation with 1 mM (3) or 3 mM
ononetin (4). (C) Statistical analysis of peak current densities
in resting HEKmTRPM3 cells after addition of 50 mM nifedipine
and different concentrations of ononetin. (D–E) Similar
experiments as described for panels A–C, whereas ononetin
was replaced by naringenin. Data represent means and SEM
of at least 5–10 independent experiments for naringenin and
six independent experiments for ononetin.
Figure S3 Naringenin has activating and blocking potency
in HEK293 cells stably expressing TRPM8. (A) Examples of
calcium entry traces from Fluo 4-loaded HEKhTRPM8 cells
activated with different concentrations of naringenin
and menthol. Challenging the cells with naringenin
concentration-dependently prevented the subsequent activa-
tion with 300 mM menthol. (B) Example of a whole-cell
recording of a HEK293 cell stably expressing TRPM8. The cell
was either perfused with 100 mM naringenin alone, simulta-
neously with 300 mM menthol or after an activation of
TRPM8 with 300 mM menthol. Note the partial activation of
outward currents and the block of menthol-induced currents
in the presence of naringenin.
Figure S4 Ononetin does not activate TRPA1 in whole-cell
patch clamp measurements, but it activates DTT-dependent
TRPA1 in fluorometric measurements. (A–B) Representative
whole-cell recordings from HEK293 cells stably expressing
TRPA1. Cells were first perfused with 10 mM (A) or 30 mM
ononetin (B). An additional perfusion with AITC (10 mM)
induced TRPA1 currents. (C–D) Examples of calcium entry
traces from Fluo4-loaded HEKhTRPA1 cells activated with differ-
ent concentrations of ononetin and 30 mM of AITC (C) and in
the presence of 10 mM of DTT (D). (E) Statistical analysis of
differences in ononetin-induced calcium entry in the pres-
ence of 10 mM DTT. Calcium entry after 30 mM AITC without
ononetin was set as maximal activation. Data represent
means and SEM of at least three independent experiments in
duplicate each. *P < 0.05; **P <0.01
Figure S5 Endogenously expressed TRPM7 in HEK293 cells
is partially blocked by naringin, whereas ononetin, hespere-
tin and eriodictyol did not affect TRPM7 currents. (A)
Representative whole-cell recordings from HEK293 cells
endogenously expressing TRPM7. Perfusion of the cells with
a solution containing no divalent cations elicited linear
TRPM7 currents. An additional perfusion with 20 mM onon-
etin, 20 mM hesperetin and 20 mM eriodictyol did not signifi-
cantly influence the TRPM7 current, whereas 20 mM
naringenin partially blocked the inward and outward cur-
rents. (B) Statistical analysis of percentage of block of 5–10
independent measurements. **P < 0.01
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 Figure S1: Concentration-response curves of naringenin-induced TRPM3 block. Whole-cell 
recordings of HEKmTRPM3 cells stimulated with 35 µM of PregS and blocked with different concentration 
of naringenin were performed to obtain concentration-response curves. To avoid that the rundown of 
the channel is considered as block, an interpolated value between before and after block was used to 
calculate the percent of block. A time-matched activation of TRPM3 without naringenin was set as 100 
% and measurements in the presence of naringenin were normalized to this value. (A) Representative 
recordings of whole cell currents. Data are extracted from voltage ramps and depict the current at 87 
mV (upper trace) and -113 mV (lower trace). Dotted line: zero current level. (B) – (C) Concentration-
response curves of naringenin to block PregS-induced inward currents (B) and outward currents (C). 
IC50 values and Hill coefficients (n) were obtained by non-linear curve fitting, applying a four parameter 
Hill equation. Each data point represents S.E.M of 5 - 12 independent experiments. 
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 Figure S2: Naringenin and ononetin block nifedipine-induced TRPM3 currents in HEKmTRPM3 
cells. (A) Whole-cell recording from a HEKmTRPM3 cell stimulated with 50 µM nifedipine and 35 µM 
PregS. And further nifedipine-induced TRPM3 currents were blocked with either 1 or 3 µM of ononetin. 
Data are extracted from voltage ramps and depict current amplitudes at 87 mV (upper trace) and -113 
mM (lower trace); dotted line: zero current level (B)  IV curve of PregS- (1) and nifedipine-activated 
TRPM3 currents (2) and during an additional stimulation with 1µM (3) or 3 µM ononetin (4). (C) 
Statistical analysis of peak current densities in resting HEKmTRPM3 cells (grey bars and dashed line) 
after addition of 50 µM nifedipine and different concentrations of ononetin. (D) – (E) Similar 
experiments as described for (A) – (C), whereas ononetin was replaced by naringenin. Data represent 
means and S.E.M. of at least 5 – 10 independent experiments for naringenin and 6 independent 
experiments for ononetin. 
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 Figure S3: Naringenin has activating and blocking potency in HEK293 cells stably expressing 
TRPM8. (A) Examples of calcium entry traces from Fluo 4-loaded HEKhTRPM8 cells activated with 
different concentrations of naringenin and menthol. Challenging the cells with naringenin 
concentration-dependently prevented the subsequent activation with 300 µM menthol. (B) Example of 
a whole-cell recording of a HEK293 cell stably expressing TRPM8. The cell was either perfused with 
100 µM naringenin alone, simultaneously with 300 µM menthol or after an activation of TRPM8 with 
300 µM menthol. Note the partial activation of outward currents and the block of menthol-induced 
currents in the presence of naringenin. 
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 Figure S4: Ononetin does not activate TRPA1 in whole cell patch clamp measurements, but it 
activates TRPA1 DTT-dependent in fluorometric measurements. (A) – (B), representative whole-
cell recordings from HEK293 cells stably expressing TRPA1, cells were first perfused with 10 µM (A), 
or 30 µM ononetin (B). An additionally perfusion with AITC (10 µM) induced TRPA1 currents. (C) – (D) 
Examples of calcium entry traces from Fluo4-loaded HEKhTRPA1 cells activated with different 
concentrations of ononetin and 30 µM of AITC (D) and in the presence of 10 mM of DTT. (E) 
Statistical analysis of differences in ononetin-induced calcium entry in the presence of 10 mM DTT. 
Calcium entry after 30 µM AITC without ononetin was set as maximal activation. Data represent 
means and S.E.M of at least 3 independent experiments in duplicate each. * p<0.05; ** p<0.01 
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 Figure S5: Endogenously expressed TRPM7 in HEK293 cells is partially blocked by naringin, 
whereas ononetin, hesperetin and eriodictyol did not affect TRPM7 currents. (A) Representative 
whole cell recordings from HEK293 cells endogenously expressing TRPM7. Perfusion of the cells with 
a solution containing no divalent cations elicited linear TRPM7 currents. An additional perfusion with 
20 µM ononetin, 20 µM hesperetin and 20 µM eriodictyol did not significantly influence the TRPM7 
current, whereas 20 µM naringenin partially blocked the inward and outward currents. (B) Statistical 
analysis of percentage of block of 5 – 10 independent measurements. **p<0.01 
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ABSTRACT
Transient receptor potential melastatin 3 (TRPM3) is a calcium-
permeable nonselective cation channel that is expressed in
a subset of dorsal root (DRG) and trigeminal ganglia sensory
neurons. TRPM3 can be activated by the neurosteroid preg-
nenolone sulfate (PregS) and heat. TRPM32/2 mice display an
impaired sensation of noxious heat and thermal hyperalgesia.
We have previously shown that TRPM3 is blocked by the citrus
fruit flavanones hesperetin, naringenin, and eriodictyol as well as
by ononetin, a deoxybenzoin from Ononis spinosa. To further
improve the tolerability, potency, and selectivity of TRPM3
blockers, we conducted a hit optimization procedure by
rescreening a focused library that was composed of chemically
related compounds. Within newly identified TRPM3 blockers,
isosakuranetin and liquiritigenin displayed favorable properties
with respect to their inhibitory potency and a selective mode of
action. Isosakuranetin, a flavanone whose glycoside is con-
tained in blood oranges and grapefruits, displayed an IC50 of 50
nM and is to our knowledge the most potent inhibitor of TRPM3
identified so far. Both compounds exhibited a marked specificity
for TRPM3 compared with other sensory TRP channels, and
blocked PregS-induced intracellular free Ca21 concentration
signals and ionic currents in freshly isolated DRG neurons.
Furthermore, isosakuranetin and previously identified hesperetin
significantly reduced the sensitivity of mice to noxious heat and
PregS-induced chemical pain. Because the physiologic func-
tions of TRPM3 channels are still poorly defined, the de-
velopment and validation of potent and selective blockers is
expected to contribute to clarifying the role of TRPM3 in vivo.
Introduction
Transient receptor potential melastatin 3 (TRPM3) is
a member of the large superfamily of TRP ion channels. The
TRPM3 gene encodes a number of different alternative splice
variants (Lee et al., 2003; Oberwinkler et al., 2005; Frühwald
et al., 2012). Alternative splicing within exon 24 affects the
putative pore region, resulting in distinct biophysical proper-
ties of the permeation pathway. The TRPM3a1 variant is
predominantly selective for monovalent cations whereas
TRPM3a2, a 12-amino-acid shorter variant, forms a cal-
cium-permeable poorly selective cation channel (Oberwinkler
et al., 2005).
TRPM3a2 channels can be activated by the neurosteroid
pregnenolone sulfate (PregS), nifedipine (Wagner et al.,
2008), D-erythro-sphingosine (Grimm et al., 2005), and by
noxious heat (Vriens et al., 2011). TRPM3 is functionally
expressed in insulin-secreting pancreatic beta cells, and its
activation has been linked to insulin secretion (Wagner et al.,
2008). Furthermore, TRPM3a2 is expressed in neurons of
dorsal root ganglia (DRG) and trigeminal ganglia, where it
contributes to the detection of noxious heat in healthy and
inflamed tissue (Vriens et al., 2011). Activation of TRPM3 has
also been coupled to vascular smooth muscle cell contraction
(Naylor et al., 2010), to oligodendrocyte differentiation, and to
neuronal myelination (Hoffmann et al., 2010).
Recently, we showed that TRPM3 is blocked by citrus fruit
flavanones and fabacea secondary metabolites (Straub et al.,
2013). Flavanones, a subgroup of flavonoids, comprise the
most common group of plant-derived polyphenolic compounds
in the human diet (Manach et al., 2004). Flavonoids share
a common structure: they consist of two aromatic rings (A and
B rings) that are linked with a heterocycle (C ring) (Fig. 1A).
They can be divided into different subgroups, depending on
the oxidation of the C ring, the hydroxylation pattern of the
phenolic rings, and the substitution at the 3-position.
For a better understanding of the biologically active
flavonoid substructure that bears responsibility for TRPM3
block, we performed a rescreening of a focused library that
was composed of members of different flavonoid subgroups
and of flavanones with different substitutions on specified
This work was supported by the Deutsche Forschungsgemeinschaft (DFG)
within the framework of FOR 806 (to M.S.), and the SFBQ:2 593 (to J.O.).
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ABBREVIATIONS: AITC, allyl isothiocyanate; BAPTA, (1,2-bis(o-aminophenoxy)ethane-N,N,N9,N9-tetraacetic acid; [Ca21]i, intracellular free Ca21
concentration; DMEM, Dulbecco’s modified Eagle’s medium; DMSO, dimethylsulfoxide; DRG, dorsal root ganglia; ER, estrogen receptor; HEK,
human embryonic kidney; HPLC, high-performance liquid chromatography; MTT, 3-(4,5-dimethylthioazol-2-yl)-2,5-diphenyltetrazoliumbromid;
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receptor potential melastatin; TRPV, transient receptor potential vanilloid.
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positions. Within the flavonoids, only substances that com-
prise a flavanone backbone displayed a biologic activity to
block TRPM3. Within the flavanones, we identified isosakur-
anetin and liquiritigenin as novel potent and specific TRPM3
blockers. The novel identified compounds blocked endoge-
nously expressed TRPM3 in freshly isolated DRG neurons.
Furthermore, we demonstrate that isosakuranetin and the
previously identified hesperetin block TRPM3-related noci-
ception in vivo.
Materials and Methods
Cell Culture. Human embryonic kidney 293 (HEK293) cells used
for transient transfection were cultured in Earle’s minimum essential
medium (Invitrogen/Life Technologies, Carlsbad, CA), supplemented
with 10% fetal calf serum, 2 mM L-glutamine, 100 units ml21
penicillin, and 0.1 mg ml21 streptomycin. HEK293 cells stably
expressing myc-tagged mouse TRPM3a2 (HEKmTRPM3) were obtained
andmaintained as described elsewhere (Frühwald et al., 2012; Straub
et al., 2013). HEK293 cells stably expressing other sensory transient
receptor potential (TRP) channels (HEKhTRPA1, HEKhTRPM8:CFP,
HEKrTRPV1:YFP) were obtained by a limiting dilution method, as
described recently elsewhere (Hellwig et al., 2004; Urban et al., 2012).
Stably transfected cell lines were selected andmaintained in HEK293
medium, containing 400 mg ml21 G418 (geneticin). All cells were
grown at 37°C in a humidified atmosphere containing 5% CO2. Unless
otherwise stated, cells were seeded 24 hours before the experiments
onto poly-L-lysine–coated coverslips.
Cell Transfection. HEK293 cells were transiently transfected
with a bicistronic expression plasmid, encoding Myc-tagged TRPM1
and enhanced green fluorescent protein, as previously described
elsewhere (Lambert et al., 2011; Straub et al., 2013). For heat
activation of TRPM3, HEK293 cells were transiently transfected with
a bicistronic plasmid encoding TRPM3a2 and a green fluorescent
protein protein. For detailed information, see Straub et al. (2013).
DRG Neuron Preparation. Eight-week-old male and female
Wistar rats were sacrificed by an overdose of CO2. To expose the
spinal cord, a careful single dorsal-midline incision along the entire
length of the body was made. The spinal cord was then gently
removed, and dorsal root ganglia from all cervical, thoracic, and
lumbar segments were obtained. Ganglia were digested for 35
minutes at 37°C in an enzyme solution containing 1.5 mg ml21
collagenase (Sigma-Aldrich, St. Louis, MO) and 3 mg ml21 dispase
Fig. 1. Chemical structures of flavonoids
and their potency to block TRPM3. Fla-
vonoids can be divided into different
subgroups: (A) flavanones, (B) flavones
(apigenin) and flavonols (quercetin), (C)
flavanols, (D) isoflavanones, and (E) dihy-
drochalkones. To clarify the blocking-
potency of the different flavonoid sub-
groups, HEKmTRPM3 cells were incubated
with the calcium indicator dye Fluo-4.
Cells were dispensed into 384-well plates
that were prefilled with single flavonoids
(25 mM), and fluorescence intensities were
measured during PregS-induced activa-
tion of TRPM3.
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(Roche Applied Science, Indianapolis, IN) in Hanks’ balanced salt
solution (GIBCO/Life Technologies, Grand Island, NY). After re-
peated trituration with a 1-ml pipette and termination of the
digestion by adding 100 ml of fetal calf serum, the cell suspension
was centrifuged (3.5 minutes at 670g) and resuspended in Dulbecco’s
modified Eagle’s medium (DMEM), supplemented with 5% fetal calf
serum, 100 units ml21 penicillin, and 0.1 mg ml21 streptomycin. DRG
neurons used for measurement of transient receptor potential
ankyrin-like (TRPA)1-related Ca21 entry were resuspended in
a DMEMmedium additionally supplemented with 100 ng ml21 nerve
growth factor (NGF). Subsequently, droplets of cell suspension were
plated on coverslips coated with poly-L-lysine (1 mg ml21; Sigma-
Aldrich), placed in a culture dish, and left to adhere for at least 1 hour
in an incubator (37°C, 5% CO2). Afterward, the culture dish was then
filled with DMEM. All experiments were performed within 36 hours
after preparation.
Intracellular Ca21 Analysis in Cell Suspensions. All fluoro-
metric assays in cell suspensions were performed in 384-well plates.
For detailed information, see Nörenberg et al. (2012) and Straub et al.
(2013). Shortly, HEK293 cells stably expressing TRPM3 were
incubated with fluorescence-indictor dye Fluo-4/AM (4 mM; Molecular
Probes/Life Technologies, Eugene, OR) for 30 minutes at 37°C,
washed, and resuspended in HEPES-buffered solution,Q:3 containing
135 mM NaCl, 6 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5.5 mM D-
glucose, and 10 mM HEPES adjusted to pH 7.4 with NaOH.
Fluorescence was monitored with a filter-based plate reader device
(Polastar Omega; BMG Labtech, Offenburg, Germany) in the bottom-
read mode, applying 485\10-nm and 520\20-nm bandpass filters for
excitation and emission, respectively. Measurements of agonistic
properties of the compounds were performed using a custom-made
fluorescence plate imaging device built into a robotic liquid handling
station (Freedom EVO 150; Tecan Group, Männedorf, Switzerland),
as recently described elsewhere (Nörenberg et al., 2012).
Single-Cell CalciumMeasurement. Single-cell measurement of
[Ca21]i in rat DRG neurons and in transiently transfected HEK293
cells was performed as previously described elsewhere (Straub et al.,
2013). All measurements were performed at room temperature (22–
24°C).
Whole-Cell Patch-Clamp Measurements. All electrophysio-
logic measurements were performed in the whole-cell voltage-clamp
mode at room temperature, using an Axopatch 200B amplifier,
connected to a desktop computer via a Digidata 1200 digitizer (Axon
CNS; Molecular Devices, Sunnyvale, CA) under the control of the
Pclamp 9 or Pclamp10 software (Molecular Devices). ToQ:4 obtain I/V
curves, Vh was set to 2113 mV for 100 milliseconds, and voltage
ramps from 2113 to 1 87 mV (0.4 mV ms21) were applied once per
second. The intersweep holding potential was213mV. Concentration
response curves were obtained with a voltage step protocol by
repeatedly applying a Vclamp of 2113 mV and 187 mV (duration of
50 milliseconds each) every 200 milliseconds. TRPM3 currents
typically reached a steady state within less than 15 milliseconds
and were averaged over a time window of 20–50 milliseconds after
applying voltage steps. The intracellular solution contained 80 mM
Cs-aspartate, 45 mM CsCl, 4 mM Na2ATP, 10 mM HEPES, 10 mM
BAPTA [(1,2-bis(o-aminophenoxy)ethane-N,N,N9,N9-tetraacetic
acid], 5 mM EGTA pH 7.2 adjusted with CsOH. The osmolarity was
300–315 mOsm. The extracellular solution used contained 145 mM
NaCl, 3 mM KCl, 10 mM CsCl, 2 mM CaCl2, 2 mM MgCl2, 10 mM
HEPES, 10 mM D-glucose, pH 7.4 adjusted with NaOH. The Cs1
-based, divalent-free external solution for TRPM7 measurements
contained 130 mM CsCl, 50 mM mannitol, 10 mM HEPES, pH 7.4
with CsOH. The liquid junction potential between the bath and the
pipette solutions was 13 mV (calculated with Clampex; Axon
Instruments/Molecular Devices) and corrected. Series resistances
were ,10 MV and were compensated by 75–85%. The sampling rate
was 5 kHz in standard whole cell measurements. For whole-cell
measurements in DRG neurons, the extracellular solution contained
140 mM NaCl, 4 mM KCl, 2 mMMgCl2, 100 nM tetrodotoxin, 10 mM
TRIS Q:5(pH 7.4 with HCl), and the pipette solution contained 140 mM
CsCl, 0.6 mMMgCl2, 1 mMEGTA, 10mMHEPES, 5mMTEA (pH 7.2
with CsOH).
To determine the I-V Q:6relationship of PregS-induced currents,
measurements were performed under monovalent free extracellular
conditions to suppress other cationic conductance present in DRG
neurons. The monovalent free solution contained 2 mM CaCl2, 2 mM
MgCl2, 10 mMHEPES, 280 mM D-mannitol (pH 7.4 withN-methyl-D-
glucamine). The holding potential for measurements in DRG neurons
was 260 mV between voltage ramps. Voltage ramps were applied as
described for measurements in HEK293 cells. Modulators were
applied via a SF-77B Perfusion Fast Step system (Warner Instru-
ments, Hamden, CT). Heat activation of TRPM3 was performed as
described earlier (Straub et al., 2013). Shortly, solutions were heated
with an inline solution heater (Warner Instruments) under control of
a TC-324B heater (Warner Instruments). The temperature of the
solutions was recorded with the pClamp 10 software (Molecular
Devices).
Giant Excised Patch Electrophysiology. Experiments were
performed with oocytes from Xenopus laevis obtained from EcoCyte
Bioscience (Austin, TX). A cRNA was synthesized in vitro from
a TRPM3a2-encoding cDNA subcloned in a pBF1-based plasmid
(kindly provided by Prof. Bernd Fakler, Freiburg, Germany) with the
mMESSAGE mMACHINE SP6 kit (Ambion/Life Technologies,
Austin, TX) according to the manufacturer’s instructions. Oocytes
were injected with 69 ml of TRPM3a2 cRNA (1000 ng/ml) and
incubated for at least 48 hour at 20°C in an oocyte medium (EcoCyte)
containing (in mM): 90 NaCl, 2 KCl, 2 CaCl2, 1 MgCl2, 5 HEPES, 0.5 g
l21 polyvinylpyrrolidone, 100 U ml21 penicillin, and 100 mg ml21
streptomycin (pH 7.2). The pipette solution contained (in mM): 115
NaCl, 5 KCl, 1 CaCl2, 10 HEPES, and 50 mM PregS (pH 7.3), yielding
pipette resistances of 200–500 kV. The bath solution contained (in
mM): 130 KCl, 2 MgCl2, 1 EGTA, 2 NaATP, and 10 HEPES (pH 7.5).
Isosakuranetin, Mg21, or dimethylsulfoxide (DMSO) was added to the
bath solution at the indicated concentrations. In all solutions, pH was
adjusted with KOH. Voltage ramps (1 mV ms21) were applied from
295.4 mV to 1104.6 mV (liquid junction potential corrected by 24.6
mV) from a holding potential of 24.6 mV at a rate of 1 Hz with an
EPC-10 amplifier controlled by the Patchmaster software (HEKA
Instruments, Bellmore, NY). Pipettes were coated with paraffin and
washed with water. Seal formation was achieved by approaching the
oocyte and releasing the positive pipette pressure after cell contact.
After a seal had been formed, a giant patch was excised by fast back-
and-forth movement of the pipette. The giant patch was placed in
front of a custom application system with three channels. By moving
the pipette, the patch was exposed to the constantly flowing solution
stream of the different application channels.
MTT Viability Test. To measure a possible cytotoxicity of the
flavonoids, enzymatic conversion of MTT [3-(4,5-dimethylthioazol-2-
yl)-2,5-diphenyltetrazoliumbromid] was assessed. HEK293 cells were
seeded onto a 96-well plate coated with poly-L-lysine (10,000 cells per
well). The next day, the cells were incubated with the compounds
diluted in cell culture medium for at least 24 hours. For colorimetric
detection, the medium was exchanged to a phenol red-free medium
(100 ml per well), containing 1.2 mMMTT, and the cells were placed in
the incubator for 4 hours. Formazan complexes that arose were
solubilized with DMSO, and absorbance was measured at 560 nm and
at 670 nm with the transmission spectrometer head of a plate reader
device (POLARstar Omega). A solvent control was set as 100%, and
measurements in presence of the indicated substances were normal-
ized to this value.
Behavioral Analysis. All animal experiments were conducted in
accordance with the accepted standards of animal care and were
approved by the local authorities (regional governmental agency of
the State of Saxony, Germany; TVV 02/12). We used 3-week-old
female and male C57BL/6J mice. For the hot plate test, isosakur-
anetin (2 mg kg21) and hesperetin (10 mg kg21) were dissolved in
Miglyol 812 (Caesar & Loretz GmbH, Hilden, Germany) containing
Selective TRPM3 Inhibitors 3
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0.1% DMSO, and compounds or the vehicle alone were injected
intraperitoneally (6 ml kg21). Thirty minutes after the injection, mice
were placed on a hot plate set to a temperature of 52°C. The delay to
the first pain-related response (hindpaw shaking, lifting or licking,
jumping) was measured by an investigator blind to substance
application. Measurements of the body temperature were performed
with a digital ear infrared thermometer (Thermoscan IRT 4520;
Braun, Kronberg, Germany) in the mouse’s armpit before and 30
minutes after injection of the compounds or vehicle.
The PregS-induced pain was assessed 30 minutes after i.p.
injection of isosakuranetin (2 mg kg21) and hesperetin (10 mg kg21)
or vehicle. PregS was solved in distilled water. A volume of 10 ml
containing 5 nmol of PregS was injected into the midplantar right
hindpaw. The latency to, duration of, and number of nocifensive
responses (paw licking, shaking, or lifting) were registered.
Plasma Concentrations. Plasma concentrations of isosakurane-
tin were determined withmodifications according to (Vega-Villa et al.,
2008). Male and female mice were i.p. injected with 2 or 10 mg kg21
isosakuranetin, and whole blood samples were collected under
anesthesia by heart puncture. Blood samples were centrifuged to
obtain the plasma, and 200 ml of plasma were mixed with 25 ml of
ethoxycoumarin (4 mM in acetonitrile) as internal standard and 600 ml
of ice-cold acetonitrile. The plasma was stirred for 1 minute and
centrifuged at 12,000g for 5 minutes. The supernatant was
evaporated at 40°C under nitrogen, reconstituted in 100 ml of 30%
acetonitrile containing 0.2% aqueous phosphoric acid (v/v), and
centrifuged. Cleared supernatant (20 ml) was injected onto a high-
performance liquid chromatography (HPLC) column (5 mm, 3 mm !
150 mm; UltraSep ES PHARM RP18E; SepServ HPLC, Berlin,
Germany) implemented in a HPLC system with absorbance detection
at 288 nm (1100 series; Agilent Technologies, Böblingen, Germany).
Separation was performed isocratically at 30°C with a mobile phase
consisting of 44% acetonitril in 0.2% aqueous phosphoric acid (vol/vol)
with a flow of 0.55 ml min21.
Stock Solutions and Drugs. All modulators were dissolved in
DMSO, if not indicated otherwise. The concentration of stock
solutions was chosen in such a way that the DMSO concentration in
the final solution never exceeded 0.14% at the highest test
concentration of the respective modulator and further reduced by
serial dilution of the compounds. PregS, pinocembrin, 49-hydroxy-
flavanone, liquiritigenin, phloretin, formononetin, ononetin, and
hesperetin were purchased from Sigma-Aldrich. Isosakuranetin was
purchased from Roth. Q:7
Statistical Analysis. All data are expressed as mean 6 S.E.M.
The number of cells analyzed in each experiment is indicated in the
figure legends. To test for statistically significant differences, analysis
of variance with the Tukey post hoc test was used. P , 0.05 was
considered statistically significant. The pharmacochemical properties
Fig. 2. Identification of isosakuranetin and liquiritigenin as novel potent inhibitors of TRPM3. Fluo4-loaded HEK293 cells stably expressing TRPM3
were incubated with different concentrations of isosakuranetin and liquiritigenin, and the fluorescence intensities were measured during injection of the
TRPM3 activator pregnenolone sulfate (PregS). (A) Examples of calcium entry traces extracted from a single 384-well plate measurement. Each trace
represents a different liquiritigenin concentration. Light gray trace shows a solvent control. (B) Concentration-response curve of liquiritigenin. TRPM3
activation without an inhibitor (DMSO control) was set as 100%, and fluorescence intensities evoked by solutions containing inhibitors were normalized
to this value. (C and D) Similar experiments as described for isosakuranetin. (C) Example traces of a single 384-well measurement with different
concentrations of isosakuranetin. (D) Concentration-response curve of isosakuranetin. Data represent at least four independent experiments for
liquiritigenin and five independent experiments for isosakuranetin with duplicates of each. Shown are mean 6 S.E.M. IC50 values and Hill coefficients
(n) were obtained by nonlinear curve fitting, applying a four parameter Hill equationQ:12 .
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of isosakuranetin and liquiritigenin were obtained from www.chemic-
alize.org.
Results
Identification of Novel TRPM3-Blocking Flavanones.
The three previously described TRPM3 blockers (Straub et al.,
2013)—naringenin, hesperetin, and eriodictyol—differ chem-
ically only in the substitutions on the B ring of the flavanone
structure (Fig. 1A). These different substitutions account for
differences in the potency to block TRPM3 and for the
differences in the selectivity (Straub et al., 2013). We now
tested whether flavanones with different modifications at the
A or C rings are still capable of blocking TRPM3 (Fig. 1).
HEK293 cells stably expressing TRPM3 (HEKmTRPM3) were
incubated with the fluorescent calcium indicator dye Fluo-4,
dispensed into 384-well plates that were prefilled with
different concentrations of the flavonoids, and PregS (35
mM)-induced calcium entry was measured. Although weakly
potent, 49-hydroxyflavanone, a flavanone that has no hydroxyl
group on the A ring, was still a blocker (47% block at 25 mM) of
TRPM3. Liquiritigenin, a flavanone that has a single hydroxyl
group on the A ring (C7 atom), abrogated the PregS-induced
[Ca21]i signal when preincubated at a concentration of 25 mM.
Pinocembrin differs from the potently TRPM3-blocking
naringenin by a complete lack of hydroxyl groups on the B
ring. It only partially inhibited the [Ca21]i signal, highlighting
the importance of these substitutions for a TRPM3 block.
Conversely, isosakuranetin features a methoxy group at the
C49 atom of the ring and completely blocked the PregS-
induced [Ca21]i entry intoHEKmTRPM3 cells at a concentration
of 25 mM.
Further, we were interested in whether the flavanone
backbone is required to block TRPM3. To this end, we
investigated several compounds from different flavonoid
subgroups, including the flavonol quercetin, the flavone
apigenin (Fig. 1B), the flavanoles epicatechin and epigalloca-
techin (Fig. 1C), the isoflavones genistein, daidzein, and
formononetin (Fig. 1D), and the dihydrochalcone phloretin
(Fig. 1E). Among the tested flavonoid subgroups, only
phloretin partially blocked the PregS-induced calcium entry
(Fig. 1B) whereas none of the others exerted more than 20%
inhibition of PregS-induced [Ca21]i signals when applied at
a concentration of 25 mM (see Fig. 1). We conclude that the
flavanone backbone and substitutions at the A and B rings are
required to strongly block TRPM3. Within the tested
Fig. 3. Electrophysiologically measured
concentration-response curves of an iso-
sakuranetin (Iso)-induced TRPM3 block.
Whole-cell recordings of HEKmTRPM3 cells
stimulated with 20 mM of PregS and
blocked with different concentrations of
isosakuranetin were performed to obtain
concentration-response curves. Due to the
channel rundown, an interpolated value
between before and after isosakuranetin-
induced block was used to calculate the
percentage of the block. (A and B) Repre-
sentative recordings of whole-cell currents
obtained from voltage steps from 2113
mV (s, lower trace) to 87 mV (d, upper
trace). Dotted line: zero current level. (C)
Concentration-response curves of isosa-
kuranetin to block PregS-induced inward
currents (s, 2113 mV) and outward
currents (d, +87 mV). IC50 values and
Hill coefficients (n) were obtained by
nonlinear curve fitting, applying a four
parameter Hill equation. Each data point
represents the mean 6 S.E.M of 5 to 12
independent experiments. (D) Repre-
sentative whole-cell currents from a
HEKmTRPM3 cell activated with 35 mM of
PregS and blocked with 3 mM of isosakur-
anetin. Data are extracted from voltage
ramps and depict the current at 87 mV
(upper trace) and 2113 mV (lower trace).
Arrows show the respective data point
that was used to obtain the I/V curves
shown in E. (E) Current-voltage relation-
ship of PregS-induced TRPM3 currents 1)
before and 2) after block with 3 mM of
isosakuranetin.
Selective TRPM3 Inhibitors 5
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flavanones, isosakuranetin and liquiritigenin almost com-
pletely abrogated the PregS-induced elevations of [Ca21]i in
HEKmTRPM3 cells.
Concentration-Dependence of Liquiritigenin- and
Isosakuranetin-Induced Block of TRPM3-Dependent
Ca21 Entry and Ionic Currents. To assess the potency of
the newly identified blockers, we first performed fluorometric
Ca21 assays in HEKmTRPM3 cell suspensions that were
exposed to serially diluted compounds and then stimulated
with 35 mM PregS. Liquiritigenin elicited a half-maximal
block with an IC50 of 500 6 70 nM (Fig. 2, A and B).
Isosakuranetin blocked PregS-induced [Ca21]i with an IC50 of
50 6 6 nM (Fig. 2, C and D). The Hill coefficients were 0.8 for
liquiritigenin and 1.3 for isosakuranetin.
To characterize the impact of the more potently acting
isosakuranetin on TRPM3 currents, we performed whole-cell
patch-clamp measurements. To reassess the concentration-
response curves with the more quantitative electrophysiologic
method, PregS-induced currents were recorded in HEKmTRPM3
cells, and isosakuranetin was acutely added via the bath
solution at various concentrations (Fig. 3). The isosakuranetin-
induced TRPM3 block was slowly developing and recovering
after removal of the modulator (Fig. 3A). Isosakuranetin
blocked the inward currents at 2113 mV slightly more
potently (IC50 5 80 6 13 nM) compared with the outward
currents measured at187 mV (IC505 1206 24 nM) (Fig. 3, B
and C). The Hill coefficients were 1.0 for both liquiritigenin
and isosakuranetin. Although the potency of TRPM3 block
displayed some voltage dependence, both currents were
isosakuranetin sensitive and almost completely blocked at
a concentration of 3 mM (Fig. 3D). Moreover, the current-
voltage relationship showed no prominent voltage depen-
dence of the isosakuranetin-induced TRPM3 block (Fig. 3E).
To test the biologic activity of the flavanones in the heat-
activated mode of TRPM3, we performed whole-cell measure-
ments with bath solutions heated to 37–40°C. Under these
conditions, inward and outward currents in TRPM3-
expressing cells were partially blocked by 3 mM of isosakur-
anetin (Fig. 4, A and B). Raising the temperature in
measurements with untransfected parental HEK293 cells
also yielded small inward and outward currents that
remained constant in the presence of 3 mM isosakuranetin
(Fig. 4, C and D). Thus, isosakuranetin presumably blocks the
TRPM3-mediated component of heat-induced currents.
To assess the accessibility of the binding site and to exclude
a requirement of cellular signaling cascades, we performed
giant patch inside-out measurements on X. laevis oocytes that
heterologously express TRPM3 (Fig. 5). The pipette solution
contained 50 mM PregS to activate TRPM3. The PregS-
induced currents were strongly blocked by 1 or 10 mM
isosakuranetin applied from the intracellular side (Fig. 5).
Because high intracellular concentrations of Mg21 are known
to inhibit TRPM3-induced currents (Oberwinkler et al., 2005),
the inside-out configuration of the patch was confirmed by
applying 10 mM Mg21. Because 10 mM Mg21 is expected to
eliminate TRPM3 currents, the remaining inward and out-
ward currents are likely to reflect TRPM3-unrelated leak
currents that could not be subtracted because TRPM3-
activating PregS in the pipette was present throughout the
whole experiment. Notably, inhibition by 10 mM isosakur-
anetin was equally effective as the TRPM3 block by 10 mM
Mg21. Because PregS binds to TRPM3 from the extracellular
side (Wagner et al., 2008), whereas isosakuranetin gets access
to its binding side from the intracellular side of the
membrane, a competitive mechanism is unlikely. From the
inside-out patch experiments we also conclude that isosakur-
anetin blocks TRPM3 in a membrane-confined and pre-
sumably direct fashion.
Specificity of Flavanones to Modulate Sensory TRP
Channels. To evaluate the specificity of the novel TRPM3
blockers, we first examined the impact of these flavanones on
the most closely related TRPM1. TRPM1 can also be activated
by PregS. Unlike TRPM3, TRPM1 is strongly blocked by
extracellularly applied ZnCl2 (Lambert et al., 2011). When
tested at a concentration of 10 mM, liquiritigenin had almost
no inhibitory effect on TRPM1-mediated [Ca21]i signals (Fig.
6A). The more potent TRPM3 blocker isosakuranetin reduced
PregS-induced [Ca21]i responses by about 36% (Fig. 6B). In
both experiments, ZnCl2 (100 mM) was applied as a positive
control for the TRPM1 block.
TRPM3 is expressed in DRG neurons, and its activation is
linked to thermosensation. We thus tested the ability of
Fig. 4. Isosakuranetin (Iso) blocks heat-induced TRPM3 currents in
transiently transfected HEK293 cells. (A) Representative whole-cell
recording from a HEK293 cell transiently transfected with a TRPM3-
encoding plasmid. During the recording, the superfused bath solution
was heated to 37–40°C, and outward (+87 mV) and inward currents
(2113 mV) were recorded. At 40 seconds after the onset of heating, 3 mM
isosakuranetin was added to the bath solution. Dotted line: zero current
level. (B) Statistical analysis of peak current densities in six independent
measurements performed as shown in A. (C) Representative whole-cell
currents in a nontransfected HEK293 cell recorded as described in A. (D)
Statistical analysis of peak current densities of four independent
measurements as shown in C.
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isosakuranetin and liquiritigenin to modulate other thermo-
sensitive or sensory TRP channels, including transient
receptor potential vanilloid-related (TRPV)1, TRPM8, and
TRPA1. HEK293 cell lines stably expressing the respective
TRP channel were loaded with Fluo-4/AM, preincubated with
different concentrations of liquiritigenin or isosakuranetin,
and agonist-induced increases in the Fluo-4 fluorescence were
measured. Neither liquiritigenin nor isosakuranetin had an
impact on the capsaicin (2 mM)-induced TRPV1 activation or
the menthol (300 mM)-triggered activity of TRPM8 (Fig. 7, A
and B).
The TRPA1 activation induced by allyl isothiocyanate
(AITC) was, however, concentration dependently (2–50 mM)
diminished by preincubation with either flavanone (Fig. 7, A
and B). Because the irritant sensor TRPA1 is activated by
many chemical compounds, we performed additional [Ca21]i
measurements with acutely added liquiritigenin and isosa-
kuranetin and compared the effects to those elicited by the
known TRPA1 activator AITC (30 mM). Indeed, liquiritigenin
partially activated TRPA1 when acutely added at
concentrations .20 mM (Fig. 7C). Isosakuranetin also
activated TRPA1 when added at concentrations .5 mM, and
activation of TRPA1 by 50 mM isosakuranetin reached levels
comparable to those elicited by AITC itself (Fig. 7D).
To further evaluate the specificity of isosakuranetin and
liquiritigenin among other members of the TRPM family, we
investigated the blocking potency of the TRPM3-blocking
compounds on endogenously expressed TRPM7 in HEK293
cells. TRPM7 is permanently blocked by divalent cations, but
when patched with Mg21-free pipette solution, switching to
a bath solution lacking Ca21 and Mg21 ions gives rise to large
inward and outward currents (Nadler et al., 2001). Because
TRPM7-like currents exhibit a fast rundown when using
a Na1-based bath solution, we used a Cs1-based bath
solution, as described elsewhere (Chubanov et al., 2012).
Neither isosakuranetin nor liquiritigenin (20 mM each)
affected TRPM7-dependent inward or outward currents in
HEK293 cells (Fig. 8, A and B).
Effects of TRPM3-Blocking Compounds on Cell
Viability. Because we aimed at testing biologic effects of
Fig. 5. Isosakuranetin (Iso) applied to the
cytosolic side of oocyte giant patches
blocks PregS-induced TRPM3 currents.
(A) Example recording of an inside-out
giant patch excised from a X. leavis oocyte
expressing TRPM3. PregS (50 mM), ap-
plied via the pipette to the extracellular
side of the patch, activated TRPM3 cur-
rents that were reversibly blocked with 10
mM isosakuranetin or with 10 mM Mg2+.
Data are extracted from voltage ramps
and depict the current at +80 mV (upper
trace) and 280 mV (lower trace). Arrows
indicate the time points of I/V curves
shown in B. (B) I/V curve of PregS-
activated TRPM3 currents 1) before and
during superfusion 2) with 10 mM isosa-
kuranetin or 3) with 10 mM Mg2+ (3). (C)
Similar experiment as in A, but with 1 mM
isosakuranetin. (D) I/V curve of PregS-
activated TRPM3 currents measured in
(C) 1) before and during superfusion 2)
with 1 mM isosakuranetin or 3) with 10
mMMg2+. (E and F) Statistical analysis of
currents at (E) +80 mV and (F) 280 mV
recorded in PregS-stimulated giant patches
treated with solvent (0.02% DMSO), 1 or
10 mM isosakuranetin, or 10 mM Mg2+.
Data were obtained from 5–10 indepen-
dent measurements Q:13each.
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the TRPM3 blockers in vivo, we next assessed the cytotoxicity
of the TRPM3-blocking substances in the parental HEK cell
line by applying MTT tests. Within the tested compounds,
liquiritigenin and ononetin did not significantly impair the
cell proliferation and viability (Fig. 9). Hesperetin and
isosakuranetin significantly reduced the MTT-converting
enzymatic activity only partially and at the highest test
concentration of 50 mM. Eriodictyol diminished the cell
proliferation in concentrations of 50 and 25 mM, respectively.
With an almost complete abrogation of the MTT conversion,
naringenin was the most cytotoxic compound among the
tested substances. All other flavanones were well tolerated by
HEK cells at concentrations that would completely block the
activation of TRPM3.
Effects of Flavanones on TRPM3 in Freshly Isolated
Rat DRG Neurons. To test the biologic activity of novel
TRPM3-blocking flavanones on endogenously expressed
TRPM3, single-cell calcium measurements were performed
using isolated rat DRG neurons that were loaded with the
Ca21 indicator dye Fura-2. Functional expression of TRPM3
has previously been described in small to medium diameter
neurons (Vriens et al., 2011). Therefore, all neurons that met
this criterion were selected by defining regions of interest over
single cells, and all cells that were sensitive to KCl were
considered as neurones. About 60–70% of the neurons showed
a PregS-induced calcium entry. A majority of but not all
PregS-positive neurons were also sensitive to stimulation
with capsaicin (Fig. 10, A and B). The PregS-induced calcium
entry was strongly counteracted either by 5 mM isosakur-
anetin (Fig. 10A) or by 10 mM liquiritigenin (Fig. 10B).
Becausemost PregS-sensitive DRG neurons also responded to
stimulation with 2 mM capsaicin or to 50 mM KCl, we
conclude that TRPM3 is expressed in a subpopulation of DRG
neurons that also express voltage-gated Ca21 channels and
very often TRPV1.
Likewise, PregS-induced currents in rat DRG neurons were
partially blocked upon addition of 1 mM isosakuranetin.
Similar to heterologously expressed TRPM3, the isosakuranetin-
induced TRPM3 block was reversible (Fig. 10C) and showed
a TRPM3-characteristic, outwardly rectifying current-voltage
relationship (Fig. 10, D and E). PregS-induced outward
currents were concentration dependently blocked by isosa-
kuranetin (Fig. 10F), and the potency and efficacy of the block
was comparable to that seen in HEK293 cells heterologously
expressing TRPM3 (see Fig. 3B).
Because isosakuranetin blocked TRPM3 in DRG neurons,
we retested the selectivity of isosakuranetin on other sensory
TRP channels within their native context. To this end, we
investigated the effect of isosakuranetin (5 mM and 20 mM) on
menthol- and capsaicin-induced increases in [Ca21]i in freshly
isolated DRG neurons (Fig. 11, A–D). Isosakuranetin itself
elicited a calcium entry in a small number of DRG neurons
(Fig. 11, B and C), whereas no obvious effect was observed on
menthol- and capsaicin-sensitive DRG neurons (Fig. 11D).
Because overexpressed TRPA1 was partially activated by 20
mM isosakuranetin (Fig. 7D), we performed measurements in
NGF-treated, TRPA1-expressing DRG neurons (Fig. 11, E–
H). Again, 3 of 150 and 5 of 136 DRG neurons were activated
by 5 mM and 20 mM isosakuranetin, respectively. Of note, all
of them also responded to the subsequent stimulation with
the TRPA1 activator AITC. AITC elicited increases in [Ca21]i
in 26–30% of NGF-treated DRG neurons. The previous
exposure to isosakuranetin did not cause a decrease in
AITC-induced [Ca21]i responses in all DRG neurons nor in
the AITC-sensitive subpopulation (Fig. 11H). There was also
no inhibition of KCl-induced [Ca21]i signals in DRG neurons
cultured either in the absence or in the presence of NGF.
Isosakuranetin and Hesperetin Attenuate the Sensi-
tivity of Mice to Noxious Heat and PregS-Induced Pain
Behavior. TRPM3 has previously been shown to be involved
in the perception of noxious heat in vivo (Vriens et al., 2011).
We therefore investigated nocifensive responses in mice that
were intraperitoneally injected with TRPM3-blocking flava-
nones 30 minutes before a hot plate assay.
Naringenin and hesperetin are citrus fruit flavanones that
were often used for in vivo studies inmice and even in humans
(Kanaze et al., 2007). We therefore decided to perform the in
vivo experiments with the newly identified and poorly
described isosakuranetin and with hesperetin, which has
already been published and tested in in vivo studies. We
preferred hesperetin over naringenin because naringenin
strongly impaired cell viability of HEK293 cells in concen-
trations up to 12.5 mM (Fig. 9).
The latency of nocifensive behavior assessed on a hot plate
(52°C) was significantly prolonged in mice after hesperetin
(10 mg kg21 i.p.) or isosakuranetin (2 or 10 mg kg21 i.p.)
treatment compared with vehicle-treated animals (Fig. 12A).
Note that 2 mg/kg hesperetin were not sufficient to signifi-
cantly increase the pain latency.
Because antagonists of the thermosensitive TRPV1 elicited
hyperthermia in different species such as rat and mouse
(Gavva et al., 2008; Gunthorpe and Chizh, 2009), we
measured the temperature of mice before and 30 minutes
Fig. 6. Effects of liquiritigenin and isosakuranetin on Ca2+ entry through
TRPM1. Single-cell calcium imaging experiments were performed with
HEK293 cells transiently transfected with cDNA plasmids encoding
TRPM1 and loaded with the fluorometric Ca2+ indicator Fura-2/AM.
TRPM1 was activated with 50 mM PregS alone and in the presence of (A)
10 mM isosakuranetin (Iso; n = 55) or (B) 10 mM liquiritigenin (Liqu; n =
48), followed by application of PregS alone or in combination with 100 mM
ZnCl2. Data shown are the mean 6 S.E.M. of at least four to six
independent imaging experimentsQ:14 .
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after injection of hesperetin and isosakuranetin. As shown in
Fig. 12B, the newly identified TRPM3 blocker isosakuranetin
or hesperetin attenuated the response to noxious heat in mice
without altering their body temperature at either dosage.
The endogenous neurosteroid PregS acts as a chemical
activator of TRPM3 (Wagner et al., 2008) and evokes pain
(Ueda et al., 2001). Intraplantar injection of PregS (2.5, 5.0,
and 10.0 nmol) dose-dependently elicited prolonged nocifen-
sive responses, consisting of vigorous licking and lifting of the
hindpaw, whereas the injection of the vehicle did not cause
a nocifensive behavior (data not shown). The duration and
number of nocifensive events after blocking TRPM3 by
isosakuranetin and hesperetin were measured Q:8at a PregD
dose of 5 nmol per injected paw. Isosakuranetin at dosages of
2 and 10 mg kg21 significantly diminished the duration and
the number of nocifensive movements (Fig. 12, C and D).
Hesperetin injected in the same doses did not significantly
reduce nocifensive responses. No differences in the latency to
the first response to PregS were observed (data not shown).
The antinociceptive effects of both isosakuranetin doses
were similar and more pronounced than those observed by
applying 10 mg kg21 hesperetin, indicating that
Fig. 7. Effects of liquiritigenin and isosakuranetin on other sensory TRP channels. HEK293 Fluo-4 loaded cells stably expressing the indicated TRP
channels were dispensed into 384-well plates and preincubated with either liquiritigenin (A) or isosakuranetin (B). Activation of the respective channel
was followed by measuring increases in the fluorescence intensity or in HEKrTRPV1:CFP cells by monitoring the Ca2+ influx-mediated intracellular
acidification, causing a decrease in the fluorescence intensity of coexpressed yellow fluorescent proteinQ:15 (Hellwig et al., 2004). The respective activators
are 2 mM capsaicin for TRPV1, 30 mM AITC for TRPA1, and 300 mMmenthol for TRPM8. Acute stimulation of HEK293 cells stably expressing TRPA1
with liquiritigenin (C) and isosakuranetin (D) led to an activation of TRPA1. Data represent the mean 6 S.E.M. of four to six different experiments,
performed in duplicate each.
Fig. 8. Endogenously expressed TRPM7 in HEK293 cells is not affected
by isosakuranetin (Iso) or liquiritigenin (Liqu). (A) Representative whole-
cell recordings from HEK293 cells endogenously expressing TRPM7.
Perfusion of the cells with a solution containing no divalent cations
elicited linear TRPM7-like currents. An additional perfusion with 20 mM
isosakuranetin or 20 mM liquiritigenin did not significantly influence the
TRPM7 current. (B) Descriptive statistics of 5–10 independent measure-
ments performed as shown in A.
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isosakuranetin effects may be already saturated at a dose of 2
mg kg21. Saturating effects may be caused by its higher
potency but also by a lower percentage of conjugation. We
therefore assessed the plasma concentrations that were
achieved after intraperitoneal application of 10 mg kg21
isosakuranetin. Peak concentrations were achieved about 10
Fig. 9. Effect of TRPM3-blocking flava-
nones on cell viability. HEK293 cells were
incubated with different concentrations of
TRPM3-blocking flavanones, and cell via-
bility was detected by performing a MTT
viability test. Data represent the mean
values 6 S.E.M. of at least 5–8 indepen-
dent experiments. To test for statistically
significant differences, analysis of vari-
ance with Tukey’s post-hoc test was per-
formed with the normalized data (*P ,
0.05; **P , 0.01).
Fig. 10. PregS-evoked Ca2+ influx in rat DRG neurons is reduced by liquiritigenin or isosakuranetin (Iso). (A and B) Freshly dissociated DRG neurons
were loaded with Fura-2/AM, and the [Ca2+]i was measured in individual neurons. Cells were superfused with 50 mMPregS and simultaneously with (A)
5 mM of isosakuranetin or (B) 10 mM liquiritigenin, followed by stimulation with 2 mM capsaicin and addition of 50 mM KCl to select neuronal cells that
express voltage-gated Ca2+ channels. (C) Example trace of whole-cell currents from a freshly isolated rat DRG neuron measured in a Na+-free
extracellular solution. Data are extracted from voltage ramps and depict the current at +100 mV (upper trace) and 2100 mV (lower trace). The neuron
was perfused with 50 mM PregS alone or in combination with 1 mM isosakuranetin. (D) Current-voltage relationship 1) before stimulation and 2) after
stimulation with PregS, and 3) after addition of 1 mm isosakuranetin. (E) Current-voltage relationship of the PregS-induced current depicted as the
difference between trace 2 and 1 in D. (F) Example of a whole-cell measurement of a DRG neuron as described in D during perfusion with PregS and
various concentrations of isosakuranetin. Shown are currents at +100 mV (dotted line: zero current level).
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Fig. 11. Isosakuranetin (Iso) does not inhibit TRPM8, TRPV1, or TRPA1 channels in rat DRG neurons. Single-cell calcium imaging experiments were performed
with freshly isolated DRGneurons. (A–C) DRG neurons were superfused with solutions containing no isosakuranetin (A) or with solutions containing (B) 5 mMand
(C) 20mM isosakuranetin. DRGneurons were sequentially challengedwith 300mMmenthol, 1mMcapsaicin, and 50mMKCl. [Ca2+]i traces of cells that responded
to isosakuranetin, menthol, and capsaicin were grouped and highlighted by green, blue, and red colors, respectively. Numbers of responsive cells are given in the
application bars. (D) Statistical analysis of [Ca2+]i determined in DRG neurons treated with buffer (open bars), with 5 mM isosakuranetin (hatched bars), or with 20
mM isosakuranetin (filled bars). Colored bars reflect results determined only in menthol-positive (blue) or in capsaicin-responding (red) subpopulations. (E–G)
Experimentswere performed essentially as inA–C, but inNGF-treatedDRGneurones thatwere stimulatedwith 20mMAITC (yellow lines). (H) Statistical analysis
of all DRG neurons measured in E–G and in the AITC-positive subpopulation (yellow bars). Data represent four (A–C) or three (E–G) independent experiments for
each condition performed with DRG neurons from different animals.
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minutes after the injection, but the individual variability was
high (Fig. 12E). A mean plasma concentration of 5.0 6 1.8 mg
ml21 (17.5 6 6.3 mM) unconjugated isosakuranetin was
measured 30 minutes after intraperitoneal application and
with a lower individual variability. Plasma levels then
dropped rapidly, presumably due to fast formation of
metabolites. Thirty minutes after application of 2 mg ml21,
the mean plasma concentration of unconjugated isosakur-
anetin was 1.8 mM and may be sufficient to block TRPM3.
Fig. 12. Isosakuranetin (Iso) and hesperetin
(Hes) diminish the sensitivity of mice to noxious
heat and attenuate the PregS-induced pain
behavior. (A) Mice were intraperitoneally injected
with solvent (control), with 2 mg kg21 and 10 mg
kg21 isosakuranetin, or with 2 mg kg21 and 10 mg
kg21 hesperetin and placed onto a hot plate (52°C)
30 minutes after the injection. The latency to the
first nocifensive response was recorded. (B) Body
temperature was measured before (gray bars) and
30–35 minutes after (black bars) injection of
hesperetin or isosakuranetin, respectively. (C
and D) Chemical pain was evoked 30 minutes
after i.p. application of the flavanones (performed
as described in A) by intraplantar injection of
PregS (5 nmol in 10 ml) into the right hindpaw.
The duration (C) and number (D) of nocifensive
behavioral events (paw licking, shaking, or lifting)
was recorded and counted. Data represent the
mean6 S.E.M. of 9–12 mice per group; *P, 0.05.
(E) Blood was obtained from mice sacrificed
without receiving isosakuranetin (0 minutes) or
at the indicated time points after injection of 10
mg kg21 isosakuranetin (i.p.). Concentrations of
unconjugated isosakuranetin were determined by
HPLC and ultraviolet light spectroscopy.
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Discussion
Owing to their low potency and to their known actions on
other biologic effectors, previously published TRPM3 blockers
such as the peroxisome proliferator-activatedQ:9 receptor-g-
agonistic antidiabetic drug rosiglitazone (Majeed et al., 2011)
or the nonsteroidal anti-inflammatory drug mefenamic acid
(IC50 5 6.6 mM) (Klose et al., 2011) have not been used to
investigate TRPM3 functions in vivo. Starting from the recent
finding that citrus fruit flavanones block TRPM3, we sought
to obtain nontoxic, selective, and potent TRPM3 inhibitors
that may be used in animal models of pain perception.
Hereby, the pharmacophore was confirmed, and substituent
variation led to the identification of isosakuranetin and
liquiritigenin as noncytotoxic, more potent, and selective
TRPM3 inhibitors. Both recombinant TRPM3 and TRPM3-
related [Ca21]i signals and ionic currents in DRG neurons
were strongly and reversibly inhibited. Other sensory TRP
channels or TRPM1, the closest relative of TRPM3, remained
largely unaffected at modulator concentrations that fully
blocked TRPM3. In vivo application of isosakuranetin and
hesperetin confirmed an antinociceptive effect on heat or
PregS-induced pain responses. Interestingly, the intraperito-
neal administration of both flavanones did not affect the body
temperature, an effect that would be expected for compounds
with TRPV1-antagonistic properties.
Besides a hit optimization strategy, we intended to more
clearly assign the pharmacophore of flavonoid that is required
to block TRPM3 and to assess the impact of the hydroxylation
pattern at the A and C rings. In plants, flavonoids are usually
present as glycosides. Upon enteral uptake, flavonoid glyco-
sides are metabolized in a complex fashion. After consump-
tion of naringin, the glycoside moiety is hydrolyzed by
bacteria in the distal part of the intestine (Fuhr and
Kummert, 1995), and the corresponding aglycones are
absorbed. In addition to phase I modification, flavanone
aglycones undergo three types of phase II conjugation
reactions: methylation, sulfation, and glucuronidation (Man-
ach et al., 2004). Accordingly, Silberberg et al. (2006) found
plasma concentrations of 10–17 mM naringenin but also 100–
120 nM of isosakuranetin and 230 nM hesperetin after
feeding rats with a diet containing 0.5% naringin. Unlike
naringenin, which is extensively metabolized to its glucuro-
nide or sulfate conjugates, 52% of isosakuranetin and 94% of
hesperetin remain unconjugated; therefore, they may exert
biologic activities in vivo. Conjugated flavanone aglycones are
typically eliminated, with half-times in the range of about 4 to
8 hours (Erlund et al., 2001). To avoid possible uncertainties
that may result from enteral resorption or hepatic first-pass
elimination, we applied hesperetin or isosakuranetin by
intraperitoneal injection.
Although the flavanone backbone appeared optimal for
TRPM3 block, the hydroxylation pattern strongly impacted
the potency to block TRPM3. The C79 hydroxylation at the A
ring is favorable. The missing C59 hydroxylation at the A ring
in liquiritigenin did not improve the potency to block TRPM3
compared with naringenin, but further increased the selec-
tivity of the effect and lowered the cytotoxicity in HEK293
cells. Concerning the B ring, hydroxylation at the C39 atom
appeared unfavorable, but 49-hydroxylation or 49-O-
methylation improved the potency to block TRPM3 without
strongly compromising the blocker selectivity. Thus, adding
more complex substituents at the C49 position may provide
a promising target for further investigation.
When compared with other biologic activities that have
been reported for flavanones, inhibition of TRPM3 by various
flavanones displays a distinct and unique preference. Liquir-
itigenin, a flavanone found in many plants including licorice,
is a selective and potent estrogen receptor b (ER-b) agonist
(EC50 5 36.5 nM) (Mersereau et al., 2008), which may relate
to the beneficial effects observed after applying a liquiritige-
nin-containing herbal drug (MF101 Q:10) used in traditional
Chinese medicine to treat menopausal symptoms (Mersereau
et al., 2008). Isoflavones from soybeans, such as genistein and
daizein, also act as phytoestrogens that bind to both ER-b and
ER-a (An et al., 2001; Mersereau et al., 2008), but are poorly
effective in blocking TRPM3.
Compared with our results with a higher potency of
isosakuranetin to block TRPM3, the structure relationship
for binding ER receptors differs from the structure needed to
block TRPM3. Furthermore, glycosylation of naringenin,
found in naringenin-6-C-glucoside or in naringin enhanced
the estrogenic effect (Swarnkar et al., 2012), whereas we
previously demonstrated that glycosylation in naringin and
hesperedin prevents the inhibition of TRPM3 (Straub et al.,
2013).
Besides their property to bind to ER receptors, flavonoids
modulated phase I metabolizing enzymes via binding to
proteins of the cytochrome P450 family Q:11(P450). Naringenin
and eriodictyol have been shown to block CYP1 activity, with
an IC50. 4 mM. Naringenin also inhibits CYP3A4 and CYP19
(Moon et al., 2006). With an IC50 of 0.34 mM, liquiritigenin has
been identified as a potent inhibitor of CYP19 (Paoletta et al.,
2008). Inhibitory effects of isosakuranetin on CYP1 enzyme
isoforms require concentrations in the range of 1–3 mM
(Takemura et al., 2010), and inhibition of other P450 enzymes
has, to our knowledge, not been demonstrated. We conclude
that liquiritigenin may be the TRPM3 inhibitor with the
highest selectivity compared with other TRP channels. Thus,
when used as a cell biologic tool to profile TRP channel-related
responses, liquiritigenin may be favorable. However, its
effects on P450 enzymes and its ER-b–agonistic properties
may interfere with its TRPM3-blocking properties in vivo.
Isosakuranetin, by contrast, with respect to non-TRP channel
off-target effects is a preferable compound for use in in vivo
pharmacologic studies.
The physiologic and pathophysiologic functions of TRPM3
are still poorly understood. Different splice variants that
impede on the Ca21 permeability of the pore (e.g., the a1
splicing event) (Oberwinkler et al., 2005) or even eliminate
a functional pore (Frühwald et al., 2012) further complicate
the situation. In TRPM3-deficient transgenic mice, pheno-
typic alterations hint at a role of TRPM3 in thermal pain
perception (Vriens et al., 2011), an effect that is closely
mimicked by a pharmacologic block of the channel, as
described in the present study. Considering the expression
of TRPV1 and TRPM3 in DRG neurons, the contribution of
each of the heat-sensing sensory channels to thermal pain
perception is intriguingly complex and seems redundant.
However, pharmacologic inhibition of either TRPV1 or
TRPM3 exerts similar antinociceptive effects. At present,
a cross-talk between both channels has not been described. An
efferent function of heat-sensitive, CGRP-releasing nocicep-
tive neurons has been demonstrated in neurogenic
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inflammation, but may also contribute to the pyrexia-
inducing effects of TRPV1 blockers. In contrast to TRPV1
blockers, the systemic administration of isosakuranetin did
not cause a discernible increase in the body temperature. This
observation hints to a promising feature of TRPM3 as
a potential analgesic target molecule and may provide
a strategy to avoid the adverse effects of TRPV1 blockers.
The exact reason why a TRPM3 block is not associated with
similar side effects than inhibitors of TRPV1 is not known.
Possibly, the thermal threshold of TRPM3 activation is
sufficiently high to avoid regulation by physiologic body or
skin temperatures. Likewise, the marked shift of threshold
temperatures described for TRPV1 in acidic or inflamed
tissues (Gavva et al., 2008) may not apply to TRPM3. Finally,
the population of DRG neurons that express TRPV1 or
TRPM3 is not completely identical (Vriens et al., 2011). Thus,
TRPM3 activation may not exactly mimic TRPV1-induced
responses.
Another open question relates to possible consequences of
TRPM3 inhibition other than attenuation of thermal pain
sensation. Obviously, we cannot exclude that such on- or off-
target effects may limit the therapeutic potential of TRPM3
inhibition. On the other hand, two lines of evidence support
the assumption that TRPM3 inhibition may be tolerated: 1)
the phenotype of TRPM32/2 mice is relatively mild, and 2)
TRPM3-blocking compounds identified in this study are
contained predominantly in citrus fruit that are part of our
daily diet. In TRPM32/2 mice, a partially reduced pupillary
response to light has been described (Hughes et al., 2012). In
contrast to a loss of TRPM1 that directly affects the function of
bipolar cells in the retina, thereby causing congenital night
blindness (Koike et al., 2010), the effect of TRPM3 deficiency
on pupillary responses is less pronounced (Hughes et al.,
2012). Future work will have to clarify whether acute
inhibition of TRPM3 interferes with retinal functions. TRPM3
is functionally expressed in insulin-secreting beta cells.
Although no obvious effects were observed in the resting
blood glucose level in TRPM32/2mice that exhibit no obvious
developmental or metabolic deficits (Vriens et al., 2011), the
acute application of TRPM3 blockers may cause alterations of
glucose homeostasis. Using the TRPM3-blocking flavanones,
these questions may be addressed and help to clarify possible
endocrine functions of TRPM3 in the pancreas.
As an off-target effect of flavanones, anti-inflammatory and/
or antioxidant properties may add to effects on TRPM3
specifically, if pain regimes are being tested in models of
inflammation. Such properties may thus overlap with the
pain-alleviating effects of the TRPM3 inhibitors, such as in
pain threshold tests with complete Freund’s adjuvant–
induced paw inflammation. Experimentally, the inhibition
of carrageenan-induced paw edema formation by orally
applied (50 mg kg21 day21) or intravenously injected (15 mg
kg21 day21) liquiritigenin has been demonstrated (Kim et al.,
2008). In a cell culture model using a lipopolysaccharide-
primedmacrophagelike cell line, Kim et al. (2008) observed an
inhibition of cytokine production by 3–30 mM liquiritigenin.
However, the TRPM3 block by liquiritigenin requires lower
concentrations of the flavanone. In addition, systemically
administered isosakuranetin was effective to elicit antinoci-
ceptive effects at a single dose of only 2 mg kg21. Thus, the
highly potent and selective TRPM3 blockers described in this
study may help disentangle the on-target and off-target
effects that are related to the anti-inflammatory or antioxi-
dant properties of flavanones. Within this context, a pain-
alleviating effect of eriodictyol, another flavanone with
antioxidant properties, has been described and attributed to
TRPV1 inhibition (Rossato et al., 2011). As outlined earlier,
we were unable to reproduce inhibition of TRPV1, but
demonstrated that eriodictyol efficiently blocks TRPM3.
Interestingly, the eriodictyol-induced antinociceptive effect
was not associated with hyperthermia. Likewise, the TRPM3-
blocking compounds hesperetin and isosakuranetin did not
increase the body temperature. Hence, flavanones with TRP
channel-inhibiting properties and/or inhibition of TRPM3
may provide a promising starting point to develop novel and
tolerable analgesic therapies.
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